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ABSTRACT 
Six proteins, ORC1-6, make up the origin recognition complex (ORC) that initiates 
licensing of the DNA replication origin. We have previously shown that subunit ORC1, ORC2, 
ORC3, and ORC5 are localized between the separating maternal chromosomes at anaphase II 
just after fertilization. During investigation, we identified ORC4 as having an unexpected 
localization in the polar body wherein ORC4 surrounds one set of chromosomes during both 
female meiotic divisions. The ORC4 structure, or ORC4 cage as we have termed it, eventually is 
discarded in the polar bodies while the chromosome set that does not interact with ORC4 
segregate into the oocyte.  Interestingly, none of the other five ORC proteins were found to be 
involved in this structure. In Zygotic G1, ORC4 surrounds the nuclei of the polar bodies, but was 
not detectable in the pronuclei. When the zygote entered mitosis, ORC4 was only detected in the 
polar body. At this point, the ORC4 that was in the polar body also migrated into the nuclei, 
suggesting that ORC4 or an associated protein is modified during the first embryonic cell cycle 
to allow it to bind DNA. We experimentally forced oocytes to extrude sperm chromatin as a 
pseudo-polar body and found that under these conditions, the sperm chromatin did become 
enclosed in an ORC4 cage. Next, we attempted to prevent the formation of the ORC4 cage by 
injecting peptides that contained sequences of different ORC4 protein domains into metaphase II 
oocytes just before typical cage formation. Our rationale was that the ORC4 peptides would 
block protein-protein interactions required for cage formation. Two out of six tested peptides 
prevented the ORC4 cage formation and simultaneously inhibited polar body extrusion, resulting 
in the formation of two pronuclei that were retained in the oocyte. Our previous results 
demonstrated that recombinantly expressed ORC4, which contained histidine tag at the C 
terminus, could be utilized by oocytes to form the ORC4 cage at one set of chromosomes. Using 
immunocytochemistry (ICC), we were able to show that ORC4-His tags incorporated with 
endogenous ORC4. However, we could not use these tags to study on live cells because they 
required cell fixation to identify by ICC. To test the localization of ORC4 in live cells, we 
generate a fusion ORC4-eGFP and ORC4 labeling with FlAsH. These constructs were then used 
to synthesize mRNA and microinjected into MII oocyte. Through confocal fluorescence 
fluctuation spectroscopy (FFS) measurements, we are able to record the movement of ORC4 
signals moving forward to form a cage or PB. This work provides the first evidence that the 
ORC4 plays a necessary role for polar body extrusion. 
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CHAPTER 1. INTRODUCTION 
1.1 DNA replication:  
The process of cellular division is an essential event for all living organisms whereby a 
cell splits into identical cells. Production and replication of cellular components is required 
during this event as the daughter cell gains genetic identity. DNA is a molecule consisting of a 
double helix of two DNA strands composing of four types of nucleotide subunits. When DNA 
replicates, these strands are separated and each strand of the original DNA serves as a template 
for producing a replica strand. In eukaryotic cells, the mechanisms that control DNA replication 
evolved to contain stringent regulations thus ensuring the maintenance of genome integrity (1). 
DNA replication is initiated at origin sites (i.e., specific sites wherein DNA replication initiates) 
in the chromosomes which serve to recruit essential protein components for initiation of DNA 
replication. The first known complex to bind to DNA replication initiation sites is the origin 
recognition complex (ORC), which functions by binding to chromosome origin sites in an ATP-
dependent manner. ORC consists of six subunits (ORC1, ORC2, ORC3, ORC4, ORC5, and 
ORC6) that play an essential role in the initiation of DNA replication by identifying the DNA 
sequences that will serve as origins. The ORC serves to bind an unlicensed origin and to recruit 
Cdc6 and Cdt1 to chromatin sites generating the pre-replication complex (pre-RC). This pre-RC 
allows the bound DNA site to transition from unlicensed to a licensed origin by loading of the 
Mcm2-7 double hexamer. The binding of Mcm2-7 destabilizes and releases ORC, Cdc6, and 
Cdt1 at that site in the interphase nucleus. The ORC, Cdc6, and Cdt1 can then be exposed to a 
new origin site on the chromosome (2). The pre-RC assembly is required for replication 
licensing of chromosomes prior to DNA synthesis during S phase of meiosis. While this 
simplified description can serve as a general model for the initiation of DNA replication, origin 
licensing is actually rather complex and can have variations depending on the cell type (Fig. 1.1). 
In Eukaryotic cells, DNA replication initiates at multiple origins distributed throughout the entire 
genome. This process is a necessary event in evolution allowing the genome to increase in 
complexity and size (3). The initial regulation of DNA replication occurs at two different time 
points. The first-time point is called “Origin licensing” in which proteins essential for replication 
assemble unto DNA and form pre-RC complexes. The second-time point is called “Origin firing” 
in which the DNA is involved in the subsequent activation of helicases. Both Origin licensing 
and firing occur separately during the cell cycle to ensure that these events occur once per cell 
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cycle (4). The origin licensing occurs at mitosis and G1 phase. The process begins with the 
loading of pre-RC, which consists of proteins ORC1-6, Cdc6, and Cdc1 bound to chromatin 
sites. It is then followed by the loading of the Mcm2-7 double hexamer. The binding of Mcm2-7 
destabilizes and releases ORC, Cdc6, and Cdt1 at that site in the interphase nucleus (2). After the 
release, the following proteins Sld5, Psf1, Psf2, and Psf3 bind and form the GINS complex.  In 
association with the pre-RC, this complex helps to recruit Mcm10 and Cdc45 which starts the 
process of DNA replication (4). In reproduction, the replication of the mammalian zygote’s DNA 
is the recombination of parental genomes (5), and this ensures the offspring inheritance of both 
paternal and maternal genetic phenotypes. Each genome is replicated independently in its 
pronuclei before the maternal and paternal pronuclei fuse together to become a single nucleus. 
This occurs just before zygotic mitosis and prepares DNA for replication at different stages of 
chromatin configuration (6). Maternal DNA exits from MII stage, but paternal DNA exits at G0 
and exchanges its protamines for histones (6) (7). DNA replication in mouse is potentially a good 
model to use and help us understand mammalian zygotic replication, because of their similarities 
in cell development. More specifically, somatic cells initiate licensing with five different proteins 
called ORC1L, ORC2L, ORC3L, ORC4L and ORC5L (2). In the first step, ORC2L-5L bind to 
many origins in the genome, which is followed by ORC1L binding to this complex (8). This 
initiates the recruitment of Cdc6 and Cdt1 to form pre-RC. This primes it and licensing can begin 
once of Mcm2-7 complexes to pre-RC. DNA replication is initiated following the recruitment of 
Mcm10, Cdc45, and DNA polymerase-α, and DNA primase (9). 
Not only is the process complex but initiation is also varied.  Analysis of ORC licensing 
in the mouse zygote revealed that ORC2 was localized at the metaphase II spindle poles 1-2 
hours after fertilization and then between the separating chromosomes at anaphase II (10). Four 
hours after activation, ORC2 was bound on DNA and remained until S phase. This showed that 
the licensed origins occur at early anaphase II and G1 after fertilization or egg activation, but 
may continue during G1 phase. Licensing occurs in an environment of low cyclin-dependent 
protein kinase (CDK) activity. Prevention of DNA replication depends on CDKs activity during 
S, G2 and M phases, resulting in inactivation of replication licensing factors changes in gene of 
licensing factors, and expression of a repressor. 
In addition to their roles in DNA replication, each protein of the ORC also plays a unique 
role in development: ORC1 in embryo growth (11); ORC2 in cell cycle regulation (12); ORC3 in 
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neuronal maturation (13); ORC5 in uterine leiomyomas and malignant myeloid diseases (14); 
ORC6 in chromosome condensation and segregation in Drosophila (15); and ORC4 in Meier-
Gorlin syndrome in human (16). During my research to investigate the localization of the ORCs 
during the two meiotic divisions in mouse oocytes and in the first cell cycle of the zygote, we 
found that ORC1, ORC3, and ORC5 has similar patterns of localization to ORC2 at anaphase II 
(17). We do not detect ORC6 at metaphase or anaphase until early G1 of the mouse zygote by 
immunocytochemistry.  
1.2 Mitosis and Meiosis 
1.2.1 Mitosis  
Mitosis is a process that follows the completion of S phase and transition through G2 in 
which a single cell with replicated chromosomes divides equally to form two new daughter cells 
containing identical cellular components, such as the cell membrane, cytoplasm, and organelles. 
The major purpose of mitosis is to induce cellular growth, repair, and reproduction to ensure that 
old, worn-out cells are replaced by new ones (18). Mitosis is divided into five phases: interphase, 
prophase, metaphase, anaphase, and telophase. 1) During interphase, the DNA has already been 
replicated into two identical full sets of chromosomes called sister chromatids in preparation for 
cell division. At this stage, the chromosomes cannot be seen very clearly because they exist in 
the de-condensed form. 2) During prophase, the chromosomes condense into X-shaped structures 
and can be easily seen under a microscope. This makes them easier to separate in the following 
phase. At the same time, the mitotic spindle a structure made of microtubules binding to the 
chromosome’s kinetochore on the centromere of each sister chromatid begins to form. At this 
phase, we also see that the membrane around the nucleus disappears, indicating that the nucleus 
is preparing to break down in preparation for metaphase. 3) During metaphase, the spindle 
attaches to all the chromosomes and aligns them neatly (from end to end) along the center of the 
cell. The two kinetochores of each chromosome are attached to microtubules from opposite 
spindle poles. Before this occurs during metaphase, the cell must pass through the spindle 
checkpoint. During this time, the cell uses a check-pathway to ensure that all chromosomes are 
on the metaphase plate and that their kinetochores are correctly attached to microtubules. If the 
chromosome is not properly aligned or attached, the cell will pause division until the problem is 
resolved. 4) During anaphase, the sister chromatids are separated from each other by the mitotic 
spindle pulling one chromatid to one pole and the other chromatid to the opposite pole. This 
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results in one chromosome per cell, which has maximum condensation to help with segregation 
and reformation of the nucleus. 5) During telophase, the mitotic spindle breaks down, the 
chromosomes begin to de-condense, and the nuclear membranes and nucleoli re-form. The 
cytokinesis undergoes to overlap with the final stage of mitosis. This cytokinesis divides the 
cytoplasm to form two daughter cells. Each daughter cell contains the same number 
chromosomes as the mother cell (19) (Fig. 1.2).  
 The mitotic process occurs under cell-cycle control of a protein M-Cdk. In addition to 
triggering chromosome condensation, this protein also induces the assembly of the mitotic 
spindle. This ensures that each sister chromatid in a pair is attached to the opposite pole of the 
spindle. M-Cdk also plays a role in animal cells by promoting the breakdown of the nuclear 
envelop and rearrangement of the actin cytokinesis and the Golgi apparatus (19).  
1.2.2 Meiosis 
Meiosis, a process to create genetic diversity, is a specialized type of cell division in 
which a single cell divides twice to produce four haploid cells. Each haploid cell contains half 
the original amount of genetic information, which is distinct from the parent cell. The genetic 
differences of four haploid cells arise by two mechanisms (19). (1) Each gamete contains either 
the maternal or paternal form of each chromosome. Because the choice of maternal and paternal 
occurs independently and randomly for each pair of homologs, each daughter cell has a unique 
mixture of maternal and paternal origin chromosomes. (2) The maternal and paternal forms of 
each chromosome have similar DNA sequences, but they are not identical, and they undergo 
genetic recombination during meiosis, a process called crossing over to produce new hydride 
forms of each chromosome. Meiosis can be divided into meiosis I, including interphase, 
prophase I, metaphase I, anaphase I, and telophase I and cytokenesis and meiosis II, including 
prophase II, metaphase II, anaphase II, and telophase II and cytokinesis (Fig. 1.3). The process of 
cell division in meiosis is similar to mitosis. However, meiosis has to reduce the number of 
chromosomes by half as many chromosomes as their diploid precursor cells. During prophase I, 
the chromosomes have replicated and consists of two sister chromatids joined tightly together. 
These homolog then pairs up side by side and undergoes genetic recombination process forming 
crossovers, occurring at metaphase I. This process plays an important role in producing off-
spring with genetic differences from each other. Like mitosis, the pair of crossover chromosome 
are pulled apart by the meiotic spindle, pulling each chromosome to one pole of the cell and 
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complete telophase and cytokinesis. After meiotic I, meiotic II occurs rapidly without DNA 
replication (Fig. 1.3). This process is resemble to mitosis (19). 
1.3 Polar body Extrusion 
During early embryogenesis, primordial germ cells migrate to the developing gonad. 
These cells proliferate through mitotic cell division before initiating symmetric cell division 
during Meiosis I and II. Two rounds of meiotic division generate a large haploid oocyte, which 
maintains most of the maternal stores in addition to two very small cells called polar bodies (20). 
During the first meiotic division, homologous chromosomes are segregated, and genetic diversity 
is created by crossing over at the chiasmata (21). When homologous chromosome separation is 
triggered, the Meiotic I (MI) spindle has reached a subcortical location. This results in the first 
asymmetric division the extrusion of one set of chromosomes in the first polar body (PB1). The 
remaining chromosomes in the oocyte then form the metaphase II (MII) plate. Upon fertilization, 
meiosis triggers and a second asymmetric cell division that leads to the formation of the second 
polar body (PB2) (22). During the second meiotic division, sister chromatids are segregated in a 
form that resembles mitotic cell division (23). Mouse oocytes are one of the best models for 
studying and understanding this meiotic process (Fig. 1.4).  
Polar body extrusion is dependent on the positioning of the metaphase plate near the 
oocyte membrane, or cortex. Following germinal vesicle breakdown (GVBD), the meiotic I 
chromosome-spindle is aligned in the center of the oocyte, but shortly afterwards, the 
chromosome-spindle initiates a migration towards the nearest cortical region of one side of the 
cortex. This process establishes cortical polarity by an actin-enriched domain surrounded with a 
myosin ring (24). Actin is essential for the survival of most cells, and the protein actin forms 
filaments that provide cells with the internal mechanical support and driving force needed for 
movement to the cortex. Actin polymerization also contributes to the internalization of 
membrane vesicles to control the composition of the cell membrane and the interface of the cell 
with the environment. Interaction of actin filaments with myosin proteins yields two types of 
movements. First, myosin generates force between actin filaments, producing contractions that 
pull up the rear of moving cells, pinch these cells in two, and induce a change in cellular shapes 
to form tissue. Second, myosin associated with subcellular organelles and macromolecular 
complexes of proteins and RNA moves these cargos along actin filaments over short distances 
(25). During Anaphase II, coordinated protrusion of the actin-enriched domain and constriction 
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of the myosin ring lead to extrusion of the first polar body which contains one set of homologous 
chromosomes (22, 26). Following the first polar body extrusion, the oocytes proceed into 
metaphase of meiosis II (MII) where an MII spindle is assembled near the first division site 
beneath the cortex. A cortical actomyocin domain similar to that in MI is again established above 
the spindle. The oocyte is now fully mature and arrested in this stage, awaiting fertilization. Both 
spindle positioning and cortical polarization rely on actin filaments but not microtubules. The 
mechanism of this cortical polarization is poorly understood. Deng et al (27) reported that the 
role of the GTPase Ran involves chromatin signaling to control cortical polarity during polar 
body extrusion in mouse. Ran (RAs-related Nuclear protein), GTP-binding nuclear protein Ran, 
is a small G protein essential for translocation of RNA and proteins through the nuclear pore 
complex. The Ran protein is also involved in the control of DNA synthesis and cell cycle 
progression (27). Dehapiot et al, 2013 reported that generating mutations in Ran has been shown 
to disrupt DNA synthesis. The GTP/GDP activates Ran via exchanging factor RCC1 that is 
bound to chromatin. This results in the generation of a Ran-GTP gradient concentrated on the 
meiotic chromosomes in mouse oocytes. Disruption of Ran-GTP in mouse blocks chromatin-
induced cortical polarization (28) . Moreover, Halet et al, 2007 found that the mechanism of the 
asymmetric meiotic divisions generating one large oocyte and two small polar bodies involves 
Rac. Polarization of Rac activation occurs during spindle migration and is concentrated at the 
chromatin nearest to the cortex. Inhibition of Rac during oocyte maturation blocks pro-
metaphase I and spindle migration. This inhibition also caused the spindle to detach from the 
cortex and prevented polar body extrusion in metaphase II arrested oocytes (29). In addition, 
Dehapiot et al, 2013 showed that polar body extrusion occurs via a functional Cdc42/N-WASP 
pathway. The activated Cdc42 (Cdc42-GTP) concentrates at restricted cortical regions on 
meiotic chromosomes. This activation form is required for recruitment of N-WASP and the 
formation of F-actin-rich extrusion during polar body formation. Inhibition of Cdc42 in MII 
oocytes caused the release of N-WASP into cytosol, a loss of the polarized F-actin cap, and a 
failure to form a second polar body. The inhibition of Cdc42 also results in defection of central 
spindle in activated MII oocytes (22). In mouse oocytes, activators Arp2/3, Cdc42 and Rac are 
essential for oocyte polarization, spindle formation and migration during meiosis (30). The 
Arp2/3 complex, upstream of N-WASP, has been shown to regulate actin nucleation and actin 
filament networks required for various cellular processes, including cell migration and adhesion, 
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endocytosis, and establishment of polarity during oocyte meiosis (30). Sun et al, 2011 
demonstrated that disruption of Arp2/3 complex by a newly-found specific inhibitor CK666 as 
well as iRNA-Arpc2 and iRNA-Arpc2 resulted in the failure of asymmetric division, spindle 
migration, and the formation and completion of oocyte cytokinesis (31). Rohatgi et al, 1999 also 
demonstrated that the C terminus of N-WASP binds to Arp2/3 complex and stimulates its ability 
to nucleate actin polymerization therefore they contain a core mechanism that directly connects 
signal transduction pathways to the stimulation of actin polymerization (30). Moreover, 
Dynamin 2 is also involved in spindle migration and polar body extrusion (32). Dynamin 2, 
located at the cortex and around the spindles of the cell, is involved in actin recruitment and 
actin-based vesicle mobility. Wang and colleagues (32) showed that actin cap formation was 
disrupted using iRNA dynamin 2. In general, cortical structure is established depending on 
signals from chromosomes (Fig. 1.5). The cortical actomyosin cap is a structure necessary for 
polar body extrusion. When the spindle is located at the vicinity of the cortex, the chromatin-
mediated Ran gradient activates N-WASP, the Arp2/3 complex, and dynamin 2 via Cdc42 at the 
cortex to nucleate actin polarization to suppress premature myosin II ring contraction and to 
drive cytoplasmic streaming keeping the chromosomes and spindle in place (24). 
The result of two rounds of meiotic division generates two polar bodies. The first polar 
body contains two sets homologous chromosomes, whereas the second polar body contains a 
haploid set of chromatids. The two polar bodies are degraded shortly after formation, but they 
provide beneficial genetic information about the egg’s genetic background. Therefore, many in 
vitro fertilization’s clinics have used polar body biopsies in pre-implantation genetic diagnosis to 
detect genetic and chromosomes abnormalities, which may be inherited by the offspring (33). 
Moreover, the two polar bodies have also been applied in research to prevent transmission of 
inherited mitochondrial disease (34).  In humans, the mutated mitochondrial DNA (mtDNA) may 
develop many severe diseases such as diabetes, heart disease, liver failure, infertility, deafness, 
blindness, and cancer, but the presentation and treatment of mtDNA are less efficient because of 
the genetic revolution, as the mutated mtDNA and normal mtDNA present on cell. The pre-
implantation genetic diagnosis (PGD) can detect mutated mtDNA which may choose mtDNA 
with a low risk of mutation to transfer into the uterus (34). Another method is also applied on 
mouse model to eliminate mutated mtDNA using nuclear transfer. The first and the second polar 
bodies are used as donor genomes to replace the genome of the recipient oocytes which carried 
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mtDNA disease following two reasons. (1) The PB carries few mitochondrial, but it has the same 
genome as the oocyte. (2) The PB are also separated from the oocyte, which can be easier to 
manipulate. This method can reconstruct genetic of offspring from the first and the second PB 
(33). 
We discovered that the DNA replication ORC4 forms a cage surrounding one set of 
chromosome which will be extruded in both polar bodies during anaphase and G1. This unique 
cage is necessary to help cells reduce the 4N meiotic genome to the haploid stage, which is 
necessary for normal fertilization. Understanding the role of ORC4 on PBE will provide us 
different aspects of PBE mechanism. Several mechanisms have been shown to be important for 
PBE, including Ran gradient, N-WASP (35), Cdc42 (22), Formin-2 (36), Arp2/3 (31), and actin 
polarization (37) and others, but none of these mechanisms is unique to PBE and to asymmetric 
cell division. In addition, our preliminary data showed that the ORC4 also surrounds extruded 
chromosomes in erythrocyte cells. This implies that ORC4 may play roles in other asymmetric 
cell divisions. In assisted reproductive technologies, it is possible that ORC4 deletion can cause 
the generation of aneuploidy. The PBE has clear significance on human assisted reproduction, 
but we cannot perform this study on human embryo because of ethical concerns. However, 
murine ORC4 protein has a high degree of homology with the human ORC4, so the mouse 
embryo may be a good model to study this aspect on human in vitro fertilization. 
1.4 Project goals and hypotheses 
In the initial work, we have shown that ORC4, a 45-kDa, is a member of origin 
recognition complex, localizes like a cage surrounding one set of chromosomes, which will 
extrude to become the first or second polar body, respectively, at both meiotic divisions. ORC4 
remains in the polar body cytoplasm for a short time. Then, it translocates into the nucleus of the 
polar body during zygotic G1 and binds to the embryo chromatin at zygotic anaphase. This 
suggests that the function of ORC4 changes during zygotic G1 from a role in polar body 
segregation to its originally defined contribution to DNA synthesis initiation. Because ORC4 is 
associated with DNA replication (17), its asymmetrical positioning with the set of chromosomes 
that will be ejected suggests a potential relationship between the regulation of DNA synthesis 
and polar body emission. This is the first chromatin-associated protein that is asymmetrically 
associated with only the extruded set of chromosomes. 
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I therefore hypothesized that ORC4 forms a cage surrounding extruded chromosomes in 
both polar bodies during female meiosis. In chapter 2 of this dissertation I present the results 
obtained while testing this hypothesis. These data are published: 
Nguyen H, Ortega MA, Ko M, Marh J, and Ward WS. (2015) ORC4 Surrounds Extruded 
Chromatin in Female Meiosis. J Cell Biochem. 116(5):778-86 
In this first page of the work, we found that ORC4 surrounds one set of chromosomes 
based on immunofluorescent localization. We next wanted to eliminate the possibility that our 
ORC4 antibodies cross reacted with a different protein. Our attempts to inhibit ORC4 production 
with siRNA failed, but this is not surprising since immunofluorescence demonstrated that even 
GV oocytes have a large store of ORC4 localized to just below the oolemma. We therefore 
generated His-tagged murine ORC4 protein to test whether His-ORC4 injected into oocytes 
could incorporate into the ORC4 cage.  Since the ORC4 cage does not form until anaphase, we 
injected the His-ORC4 protein into MII oocytes and then activated the oocytes. Moreover, our 
previous work demonstrated that when PBE was disrupted with brefeldin, the ORC4 cage did not 
form. However, when sperm were induced to create ectopic sperm polar bodies by delayed 
activation, the ORC4 cage did form.  These data suggested that the ORC4 cage was associated 
with PBE, but it was not clear whether it was required for PBE.  To disrupt the ORC4 cage, we 
designed six 18-amino acid long peptides that represented parts of ORC4 that were on the 
exterior face of the protein, based on a predicted three-dimensional structure of ORC4. We 
reasoned that the ORC4 cage required some form of polymerization of ORC4, either with itself 
or with another protein(s), and the peptides that faced the exterior of the protein might disrupt the 
ORC4 cage by competitive binding with the polymerization sites.  
I hypothesized that the higher order oligomerization of the licensing ORC4 protein is 
required for polar body extrusion in murine meiosis. Chapter 3 of this dissertation discusses the 
following results obtained during experimental analysis. These data are published: 
Nguyen H, James NG, Nguyen L, Nguyen TP, Vuong C, Ortega M, Jameson, DM, and 
Ward WS. (2017) Higher order oligomerization of the listening ORC4 protein is required 
for polar body extrusion in murine meiosis. J Cell Biochem. 118(9):2941-2949. 
Our previous results demonstrated that recombinantly expressed ORC4, which contained 
histidine tag at C terminal of orc4 sequences, could be utilized by oocytes to form the ORC4 
cage at one set of chromosomes or PB. Using ICC, we were able to show that ORC4-His tags 
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incorporated with endogenous ORC4. However, we could not use this tags to study on live cells 
because of fixed cell preparations. We wanted to test whether enhanced green fluorescent protein 
(eGFP) or FlAsH would have the best method for determining the self-associated of ORC4 
protein to form a cage or polar body extrusion in living cells. Expanding upon this observation, 
we used mORC4 variant 1 plasmids (full length of orc4) to create two plasmids. (1) The first 
plasmid we created was ORC4 with GFP fused at the C-terminus, ORC4-GFP. (2) The second 
plasmid we created was a mutation of the ORC4 plasmid containing six-amino acids (Cys-Cys-
Pro-Gly-Cys-Cys) that replaced six amino acids at 407- 412.The ORC4-GFP and ORC4 
mutation plasmids were transcribed to mRNA and then microinjected into MII oocytes.  
I hypothesized that spatial and temporal resolution of ORC4 fluorescent variants reveals 
structural requirements for maintaining higher order self-association and pronuclei entry. In 
Chapter 4, the results obtained from testing the hypothesis were presented. These results have 
not yet been published and the investigations are ongoing.  
1.5 Contributions 
Theoretical design: Hieu Nguyen  
Contributed to writing: Hieu Nguyen 
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Figure 1.1: A model of replication licensing in live Caenorhabditis elegans embryos. The DNA 
licensing and replication occur during anaphase and S phase. (A) ORC complexes and cdc6 bind to 
unlicensed origin on DNA. (B) The origin is licensed by loading a Mcm2-7 double hexamer (M). (C) The 
ORC complexes, Cdc6, and Cdt1 are destabilized because of the binding of Mcm2-7. (D) The ORC 
complexes and Cdc6 are exported out of the interphase nucleus, whereas Cdc45 is recruited to Mcm2-7 
when replication forks initiate.  
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Figure 1.2: A diagram of mitosis stages: Prophase: the chromosomes pair up and each chromosome is 
consists of two identical sister chromatids. Metaphase: The chromosomes line up along the center of the 
cell. Anaphase: The sister chromatids pull apart by the mitotic spindle. Telophase and cytokinesis: Cell 
pinches in the middle to form two separate daughter cells each containing a full set of chromosomes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chromosomes line 
up at equator 
Sister chromatids 
pull apart 
Cell pinches in the 
middle 
Chromosomes pair up 
Interphase (G2) Prophase Prometaphase Metaphase Anaphase 
Telophase 
&Cytokinesi
s 
13 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: A diagram of meiotic stages. After DNA replication, cell is required to produce haploid 
gametes. The duplicated homologs pair up and are segregated into different daughter cells in meiosis I. At 
this stage, the homolog pairing leads to genetic recombination (crossing-over). The diploid cell enters the 
second meiotic II following with meiotic I. The final outcome is to produce four genetically different 
haploid. 
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Figure 1.4: A model of meiotic maturation of a mouse oocyte. Meiotic maturation of a mouse oocyte. 5 
hours after germinal vesicle breakdown (GVBD), the MI spindle is assembled and migrates towards one 
side of the cortex. Then, the MII spindle is formed beneath the cortex after a first polar body extrusion. 
Later, fertilization occurs to trigger meiosis II resulting a second polar body formation.  
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Figure 1.5: mechanism of polar body extrusion on mouse. The chromatin-mediated RanGTP gradient 
activates N-WASP and the Arp2/3 complex via Cdc42 at the cortex to nucleate actin polymerization. 
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CHAPTER 2. ORC4 SURROUND EXTRUDED CHROMATIN IN FEMALE MEIOSIS 
2.1 Background 
Origins are marked by ORC (origin recognition complex) proteins during the M-G1 
transition to ensure all DNA is only replicated once during S-phase (38-41). This is the first step 
of a process called licensing that serves as a bookkeeping mechanism for the cell to monitor it 
progress in duplicating the chromosomes. The ORC is made up of six proteins, ORC1-6 ranging 
from 95 to 29 kD (NCBI database). The ORC complex proteins, which are found in all types of 
cells, from bacteria, in which DnaA is structurally and functionally homologous to ORC to 
mammals and are part of a group of proteins termed replication initiators (42). The six ORC 
proteins were originally discovered in yeast and named according to size, with ORC1 being the 
largest, and the subunits in other species names according to the homology with their yeast 
counterparts (43). More studies have been done on human ORC than mouse, but the close 
homology between these two species suggests that similar mechanisms are involved in both (44-
46). Previous models for human ORC proposed that in actively dividing somatic mammalian 
cells, ORC2-5 remain associated with DNA replication origins throughout the cell cycle while 
ORC1 is recruited to the ORC complex only during G1 (38, 39, 47, 48). However, more recent 
work has suggested that it is possible all the ORC proteins are recruited to the origins during 
each cycle (49). Moreover, the DNA binding patterns of ORC to DNA vary during 
differentiation (50). 
Licensing patterns during fertilization and subsequent early embryo development are 
particularly unique.  Sonneville et al. (2) demonstrated that ORC2, one of the first ORC proteins 
to bind to naïve DNA origins in the C. elegans zygote, binds DNA only transiently, long enough 
to recruit the MCM7 helicases that represent the final step of licensing. We previously 
demonstrated that the maternal DNA is likely to be licensed before fertilization but the paternal 
DNA is licensed de novo in the embryo (10). We also identified unexpected roles for ORC2 in 
the first cell cycle. We demonstrated that ORC2 binds to the DNA in both pronuclei in late 
zygotic G1 as expected for its role in licensing.  However, just after fertilization in anaphase II, 
ORC2 localized between the two separating sets of maternal chromosomes. While the original 
role of ORC proteins was to mark DNA replication origins, it has now been suggested that they 
also play more diverse roles that coordinate DNA replication with other cell division events (42, 
51).   
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Here, we examined the roles of the other five ORC proteins in the first cell cycle. We 
found that ORC1, ORC3, and ORC5 had similar patterns of localization to ORC2 at anaphase II, 
but ORC6 and ORC4 exhibited surprisingly different patterns. In particular, the data suggest that 
ORC4 may play a role in polar body extrusion. 
2.2 Materials and Methods 
2.2.1 Animals  
Eight-week old B6D2F1 (C57BL/6N X DBA/2) mice were used.  Mice were obtained 
from National Cancer Institute (Raleigh, NC), and used at 8 – 12 weeks of age. Animal care and 
experimental protocols for handling and the treatment procedures were reviewed and approved 
by the Institutional Animal Care and Use Committee at the University of Hawai’i. 
2.2.2 Preparation of Spermatozoa  
Spermatozoa were obtained from B6D2F1 male mice (8- 12-week-old). A caudal 
epididymis was extracted, suspended in HEPES-CZB, and incubated for 45 minutes at 37°C 
under 5% CO2 in air to allow the spermatozoa to disperse in the medium. The spermatozoa 
suspension for Intracytoplasmic sperm injection (ICSI) was mixed with PVP-saline (0.9% NaCl 
containing 12% w/v polyvinyl pyrolidone 360 kDa; ICN Biochemicals) 
2.2.3 Preparation of Oocytes  
To obtain mature metaphase II (MII) oocytes, mature female, 8 – 10-week-old, were 
induced to superovulate by injections of 5 IU PMSG and 5 IU hCG given 48h apart.  Oviducts 
were removed 14 -15 hours after the injections of hCG and placed in CZB free Ca+2. The 
cumulus cells were released from the oviducts into 0.1% bovine testicular hyaluronidase/CZB 
medium for 10 minutes to disperse cumulus cells.  The cumulus-free oocytes were washed and 
kept in CZB at 37o C under 5% CO2 in air.  These oocytes were used for immunocytochemistry 
and ICSI. 
2.2.4 Intracytoplasmic Sperm Injection (ICSI)  
 ICSI was carried out as described by Kimura and Yanagimachi (52). ICSI was 
performed using Eppendorf Micromanipulators (Micromanipulator TransferMan, Eppendorf, 
Germany) with a piezoelectric actuator (PMM Controller, model PMAS-CT150; Prime Tech, 
Tsukuba, Japan). A single sperm head was sucked, tail first, into the injection pipette and moved 
back and forth until the head-mid piece junction (the neck) was at the opening of the injection 
pipette. The head was separated from the mid piece by applying one or more piezo pulses. An 
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oocyte was held to the holding pipette at the 9 o'clock position, and the sperm head was redrawn 
into the pipette and injected immediately into an oocyte. After discarding the mid piece and tail, 
the sperm head was redrawn into the pipette and injected immediately into an oocyte. After ICSI, 
oocytes were cultured in CZB at 37o C under 5% CO2 in air. 
2.2.5 Preparation immature oocytes 
To collect immature metaphase I and anaphase I oocytes, females were induced to super-
ovulate by injections of 5 IU of PMSG. Oviducts were removed 48 hours after PMSG injections 
and placed in HEPES-CZB in a petri dish. The biggest follicles were break to release germinal 
vesicle stage (GV) oocytes. GV oocytes with surrounded cumulus cells were placed in CZB 
drops under mineral oil and cultured for 2 hours.  After 2 hours, cumulus cells were removed by 
pipetting.  The oocytes that underwent germinal vesicle breakdown were collected and cultured 
for 4 and 9 hours to reach metaphase I and anaphase I, respectively. Oocytes were then used for 
ICC. 
2.2.6 Antibodies 
Polyclonal goat anti-ORC1 (N-17, catalog no. sc-13231; Santa Cruz Biotechnology), 
polyclonal goat anti-ORC2 (C-18, catalog no. sc-13238; Santa Cruz Biotechnology), Polyclonal 
goat anti-ORC3 (K-17, catalog no. sc-21862; Santa Cruz Biotechnology), Polyclonal goat anti-
ORC4 (C-15, catalog no. sc-19726; Santa Cruz Biotechnology), Polyclonal goat anti-ORC5 (T-
15, catalog no. sc-19728; Santa Cruz Biotechnology), Polyclonal goat anti-ORC6 (2679C2b, 
catalog no. sc-81646; Santa Cruz Biotechnology) and monoclonal mouse-MCM7 (H-5, catalog 
no. sc-374403; Santa Cruz Biotechnology) primary antibodies were used. The Secondary 
antibodies included Alexa Fluor 488 rabbit anti-goat and Alexa Fluor 546 rabbit anti-mouse 
(Invitrogen, Grand Island, NY). 
2.2.7 Immunocytochemistry (ICC) 
Embryos were cultured in CZB until they reached the desired stage after ICSI, and fixed 
in 2% paraformaldehyde for 30 minutes at room temperature. After fixing, cells were washed 
three times with 0.1% Tween/PBS (PBSw) for 10 minutes. Cells were permeabilized in 0.5% 
Triton X-100 for 15 minutes, after that the cells were washed three times with PBSw contained 
10% volume of 5% BSA. Cells were blocked with 5% BSA for 1 h at room temperature, then 
incubated in primary antibody at 1:50 dilution overnight at 4 o C. Again, the cells were washed 
three times with PBSw contained 10% volume of 5% BSA, then incubated in secondary antibody 
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at 1:1500 dilutions at room temperature for 45 minutes. Cells were again washed three times 
with PBSw contained 10% volume of 5% BSA then mounted with ProLong Gold antifade 
reagent with DAPI (catalog no. P-36931; Invitrogen).  ICC was analyzed with an FV1000-IX81 
confocal microscope from Olympus using Fluoview v. 2.1 software.  For each stage of 
embryonic development, at least 20 embryos were examined by ICC, and the results were only 
reported if they were consistent in all embryos. 
2.3 Results 
2.3.1. ORC1, ORC3, ORC5 and ORC6 localize between the chromosomes at anaphase II 
similar to ORC2 
We recently examined the expression pattern of ORC2 during the first two cell cycles of 
the mouse embryo. ORC2 localizes at the area between the separating chromosomes in anaphase 
II just after fertilization, then moves into the pronuclei where it becomes resistant to salt 
extraction, indicative of DNA binding (10). To complete the analysis of the expression patterns 
of all six ORC proteins, we examined ORC1, and ORC3-6 during the first cell cycle of the 
mouse zygote. We found that ORC1, ORC3, and ORC5 behave similarly to ORC2 in that they 
localized between the separating chromosomes at anaphase II (Fig. 2.1) and to the spindle poles 
zygotic metaphase. ORC1 surrounded the chromosomes at zygotic anaphase, but did not 
significantly overlap with the chromosomes, just as we had previously seen for ORC2 (10). This 
suggests that ORC1, ORC2, ORC3 and ORC5 may play structural roles during mitosis. ORC1, 
ORC3 and ORC5 could not be detected in the zygotoc pronuclei, however (data not shown). This 
differs from ORC2, which is easily detectable in the zygotic pronuclei at all stages (10). ORC6, 
on the other hand, was found only in the periphery of the nucleoli at all stages between zygotic 
G1 and 2-Cell G1 (Fig 2.2). During zygotic telephase, ORC6 was present around the nucleoli of 
the polar body, but was not detectable on the chromosomes (data not shown). 
2.3.2 ORC4 surrounds the polar body chromatin at anaphase II 
We were surprised to find that ORC4 behaves in a very different manner than the other 
ORC proteins. At anaphase II, ORC4 formed a ring, as visualized by confocal microscopy, 
around the set of chromosomes that would eventually segregate into the second polar body (Fig. 
2.3B). Two different antibodies gave us the same result. This was a consistent finding in every 
zygote at anaphase II for which ORC4 staining was clear. ORC4 always surrounded the 
chromosomes that were nearest the zygotic membrane, and therefore presumed to be those 
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destined to segregate into the second polar body. This assumption is supported by the fact that in 
zygotic G1 after the polar body had been extruded, ORC4 was localized to the nuclear periphery 
of the polar body nucleus (Fig. 2.3L).  ORC4 was not detectable in the pronuclei in the zygote at 
this stage.  The decondensing sperm chromatin in the zygote after fertilization was initially not 
associated with ORC4 (Fig. 2.3B), but as decondensation progressed, ORC4 was found to be 
associated with sperm chromatin in a 3/12 zygotes (Fig. 3G, inset).  At this point, ORC4 also 
bound to both sets of maternal chromatin, the one that would contribute to the maternal 
proncleus (Fig. 2.3G, arrow) and one that would be segregated into the polar body (Fig. 2.3G, 
arrowheads). The fact that so few zygotes had ORC4 bound to the sperm chromatin suggested 
that this binding seemed to be transient. Neither of the two pronuclei at zygotic G1 had 
detectable ORC4 (Fig. 2.3L). 
2.3.3 ORC4 also surrounds first polar body chromatin 
 The results described above suggested that ORC4 may play a role in polar body extrusion. 
To test this, we examined whether ORC4 localized to the chromatin or perinuclear cytoplasm 
during the first division of female meiosis. We isolated oocytes at the germinal vesicle (GV) 
stage which is the point just before metaphase I, and cultured them for 8 to 9 hours until they 
reached metaphase I and anaphase I. At both the GV and GVBD (germinal vesicle breakdown) 
stages, ORC4 was present in a thin shell just below the cell membrane (Figs. 2.4A-D). At 
metaphase I, this layer became more diffuse (Figs. 2.4E and F). At anaphase I, ORC4 surrounded 
the polar body chromosomes, but not the oocyte chromosomes (Figs. 2.4G and H), just as in 
anaphase I (Fig. 2.3G).  Because ORC4 seemed to play similar roles in anaphase I and anaphase 
II, we tested whether the same was true for ORC2. We found that ORC2 localized between the 
separating chromosomes of anaphase I, just as it does in anaphase II (10).  Once the first polar 
body was extruded, at metaphase II, ORC4 surrounded the polar body nucleus (Figs. 4I and J). 
These data support the possibility that ORC4 plays a role in the extrusion of both polar bodies. 
Because the ring-like structures for the ORC4 complex were seen by confocal microscope 
sections, we tested whether the three dimensional structure was actually an ovoid sphere that 
completely enclosed the polar body chromatin. Figure 2.5 shows serial confocal sections of polar 
body chromatin in late anaphase I that clearly demonstrate that ORC4 forms a sphere that 
surrounds one set of chromosomes (Figs. 2.5C-G) but not the other (Figs. 2.5A-B). 
 
21 
 
2.4 Discussion 
This work represents the completion of our study on the localization of the six ORC 
proteins during the first cell cycle of the mouse zygote. The data from this and our previous 
study (10) are summarized in Fig. 8.   
2.4.1 ORC1-3, 5 and 6 
 In the zygote, perhaps more than in other cell types, ORC proteins seem to play roles in 
addition to their well-documented function in DNA replication. ORC1-3 and 5 all localize to the 
area between the separating chromosomes in anaphase II just after fertilization, and to the 
spindle poles in zygotic metaphase. It is not clear what role these four ORC proteins play in these 
structures, but it is intriguing that all four localize at both. A recent study has suggested that 
ORC2-5 assemble in the cytoplasm before being translocated to the nucleus (49). The co-
localization of ORC1-3 and 5 at the mitotic spindle and between the separating chromosomes at 
anaphase II suggest that these are storage sites for the initial ORC complexes in close proximity 
to the newly forming nucleus. A similar localization of ORC2 between separating chromosomes 
at mitosis was previously noted in HeLa cells (53). Interestingly, ORC2 was also found at the 
spindle poles in the oocyte at metaphase I and between the separating chromosomes of anaphase 
I (10). Because both structures disappear and then re-establish in the second mitotic division of 
maternal meiosis, this suggests that ORC2 plays a role in mitosis other than licensing (54). We 
also demonstrated that ORC1 surrounded the separating chromosomes in zygotic metaphase (Fig 
2.1) just as we had previously shown for ORC2 (10). ORC2 was constantly found around the 
DNA during telophase before it moved into the nucleus, and ORC1 seems to follow this pattern. 
We found that ORC6 was localized to the nucleoli of both pronuclei and the polar body, which 
agrees with studies in Drosophila (15) and human cells (39).   
We were not able to visualize ORC1-3 or 5 co-localized with the DNA at any time.  
However, recent models for ORC suggest it might be more transiently associated with DNA than 
previously thought (43), so it is possible that we missed time points in which ORC subunits were 
associated with DNA. Our own data for ORC4 (discussed below) and ORC2 (discussed in ref. 
(10)) suggest that this is particularly true for the zygotes.  Additionally, the fully formed ORC is 
a circular complex in which the six subunits are closely associated (55). This may provide steric 
hindrance from the other ORC subunits that prevents the antibodies from finding their epitopes.   
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2.4.2 ORC4 and the Polar Body 
 The most unexpected finding in our study was the association between ORC4 and the 
polar body chromatin. We have shown that ORC4 is part of a structure that surrounds the 
chromatin as an ovoid sphere that is destined to become the first and second polar bodies in both 
female meiotic divisions.  It does not appear that any of the other ORC subunits are involved in 
this. ORC2 is located adjacent to the ORC4 sphere between the separating chromosomes in both 
divisions, and ORC1, ORC3, and ORC5 are similarly located there in anaphase II. This is 
consistent with the recent demonstration that in the first step of the formation of the ORC is the 
formation of the ORC2-5 complex, to which ORC4 binds before being transported into the 
nucleus (49). This suggests that ORC4 is capable of existing in the cytoplasm separately from the 
other ORC subunits as observed during polar body formation where an ORC4 sphere was present 
as soon as the chromosomes began to separate. In the first meiotic division, ORC4 was clearly 
present in a thin layer just below the oolemma then moved to the separating chromosomes in 
anaphase. In metaphase II, ORC4 was visible only in the cytoplasm of the first polar body, where 
it remained during anaphase II in those cases where the first polar body survived. These results 
raise the intriguing question that cytoplasmic ORC4 plays a role in the separation of the polar 
bodies from the oocyte. 
 Polar body extrusion is tightly coupled with the movement of the mitotic plate close to 
the oolemma during metaphase I and metaphase II in the maturing oocyte (56). A cortical 
domain forms over the spindle near the oolemma, and the mitotic plate is oriented perpendicular 
to the membrane (57, 58). Formin-2, a microfilament binding protein, directs the migration of the 
mitotic plate to the oolemma (59). A myosin ring helps to define the polar body cytoplasm, and 
the final emission (27).  From these studies, it would appear that the chromatin that is destined to 
be extruded in the polar body is defined not by a molecular signal but by the orientation of the 
mitotic plate in the cytoplasm:  the chromatin that is nearest to the oolemma will be extruded.  
The role that ORC4 may play in this, therefore, is not readily apparent. One possibility is that the 
ORC4 sphere stabilizes the polar body cytoplasm that will form the polar body.  In support of 
this, it is interesting to note that the de-condensing sperm nucleus also forms a cone, similar to 
the polar body that is subsequently not extruded and reabsorbed back into the oocyte (27).  It is 
not clear why the sperm cone is not extruded but the polar body cone is. We only found the 
ORC4 sphere around the polar body chromatin, and never around the sperm nucleus, and it is 
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possible that the ORC4 in the polar body cytoplasm plays a role in the eventual extrusion of the 
polar body cone.  Another possibility is that it helps to segregate the polar body chromatin from 
nuclear factors that would activate genes inappropriately. We are currently testing whether 
ablation of ORC4 will prevent polar body formation. 
2.4.3 ORC4 and Zygotic Chromatin 
 The role that ORC4 plays in polar body emission seems to be separate from its role in 
DNA replication. We have previously shown that the second polar body occasionally undergoes 
visible DNA replication (60) so it is likely that enough ORC4 binds to the DNA of the polar 
body to ensure at least partial licensing. We found that ORC4 undergoes two cytoplasmic to 
nuclear translocations in the first two embryonic cell cycles. We found three examples of ORC4 
being associated with the sperm chromatin and both sets of separating maternal chromosomes at 
anaphase II (Fig. 2.3). In all three cases, ORC4 bound to the DNA of the chromatin at the same 
time in that it formed the ORC4 sphere that surrounded the chromosomes destined to become the 
polar body. Interestingly, at this point in fertilization, the maternal chromosomes are in anaphase 
and are not contained within a nuclear membrane therefore these chromosome sets are directly 
associated with the cytoplasm. It should be noted, the decondensing sperm nucleus also does not 
have a fully formed nuclear envelope (61). This association appeared to be short-lived, consistent 
with recent studies suggesting that the ORC complex forms transient structures in some cases (2, 
43). Another possibility, mentioned above, is that ORC4 remains on the chromatin structures but 
is no longer available for antibody binding in the fully formed ORC.  In this latter case, the data 
would suggest that ORC4 plays a role in establishing the fully formed ORC as observed in S. 
pombe (62). 
 The second obvious association of ORC4 with the chromatin was in late zygotic 
anaphase. The chromosomes became coated with ORC4 as they were separating from the mitotic 
plate (Fig. 2.6). This was preceded by a clear translocation of the cytoplasmic ORC4 in the 
second polar body into the nucleus just before zygotic metaphase (Figs. 2.6B and E).  
Interestingly, in those cases where the first polar body survived unit zygotic metaphase, ORC4 
translocated into the nucleus of second polar body, but not the first (Fig. 2.6). In this case, the 
polar body DNA is sequestered inside nuclear envelope, but the zygotic anaphase chromosomes 
are not. The data suggest that the roles of ORC4 in the cytoplasm, within the nucleus, and in 
mitotic chromosomes are regulated both spatially and temporally.  It is likely that the association 
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of ORC4 with the chromatin is related to licensing. ORC4 is the only ORC subunit that we have 
localized to the zygotic anaphase chromosomes. ORC1 (Fig 2.1) and ORC2 (10) surround the 
chromosomes but do not appear to bind directly to the DNA at this point. This raises the 
intriguing possibility that ORC4 directs the formation of ORC on the chromatin. Most current 
work on human ORC suggests that it is ORC1 that directs the binding of the final complex to 
DNA.  However, in the yeast S. pombe, ORC4 has a unique domain that directs the binding of 
the ORC to the DNA (62). It is possible that mouse ORC4 plays a greater role in ORC binding to 
DNA that human ORC4. 
2.4.4 Conclusions 
 Our data suggest that the ORC subunits play important roles in the mouse zygote other 
than licensing DNA replication origins. ORC1-3, 4 and 5 may all be involved in the separation of 
chromosomes during meiosis, and ORC4 may play a role in polar extrusion. Both functions are 
related to the proper segregation of the chromosomes just before and after fertilization.   
2.5 Contributions 
Research design: Hieu Nguyen and W. Steven Ward. 
Conducted experiments: Hieu Nguyen, Michael A. Ortega, Myungjun Ko, Joel Marh. 
Contributed to writing: Hieu Nguyen and W. Steven Ward 
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Figure 2.1. ORC1-3 and ORC5 are adjacent to the chromosomes at anaphase II.  ICSI generated 
zygotes were fixed and stained for ORC1 (A), ORC2 (B), ORC3 (C) and ORC5 (D) and visualized by 
confocal microscopy. All four ORC subunits localize to the area between separating maternal 
chromosomes in anaphase II. The decondensing sperm nucleus had no visible staining in any oocyte. 
Insets in (B) and (D) represent areas in different confocal planes than the maternal chromatin. Sp, de-
condensing sperm nucleus.  All images are shown at the same magnification, bar = 10 m. 
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Figure 2.2. ORC6 in the first zygotic cell cycle.  ICSI generated zygotes were fixed and stained for 
ORC6 at zygotic G1 (A), zygotic telophase (B), and 2-cell G1 (C) and visualized by confocal microscopy. 
Inset in (C) is the area in different confocal plane from the main image that contained the second nucleus. 
PB, second polar body. All images are shown at the same magnification, bar = 10 m.  
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Figure 2.3. ORC4 surrounds the polar body chromatin during anaphase II. ICSI generated zygotes 
were fixed and stained for ORC4 at early anaphase II (A-J), early zygotic G1 (K-O) and late zygotic G1 
(P-T), and visualized by confocal microscopy.  ORC4 surrounds the chromatin that is closest to the 
oolemma (B and G), and the nucleus of the polar body at G1 (L). ORC4 was also visible in the 
decondensing sperm nucleus (G, inset) but not in a sperm that was less decondensed (B). ORC4 
translocates to the nucleus of the second polar body in late G1 (Q).  All insets show areas from different 
confocal planes than the rest of the figure. All images are shown at the same magnification, bar = 10 m. 
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Figure 2.5. ORC4 forms an ovoid 
sphere around the polar body 
chromatin at anaphase.  A GV oocyte 
was matured in vitro until it reached 
anaphase I and then fixed and stained for 
ORC4. The images are serial confocal 
planes starting at one chromosome set at 
anaphase I (A). The second set of 
chromosomes appears in (B). ORC4 
begins as a small oval shape (B and C) 
then becomes a ring (D and E) then 
becomes a solid oval, again (F to G), 
indicating that ORC4 surrounds only one 
set of chromosomes as an ovoid sphere at 
anaphase I. All images are shown at the 
same magnification, bar = 10 m. 
Figure 2.4. ORC4 in maturing oocytes. GV 
oocytes were isolated and cultured in vitro, then 
stained for ORC4 and visualized by confocal 
microscopy. GV (A and B), and GVBD oocytes 
(C and D) contained ORC4 in the cell periphery.  
Metaphase I oocytes (E and F) had more diffuse 
patterns of ORC4 distribution.  At anaphase I (G 
and H), ORC4 surrounded the chromatin nearest 
the oolemma, and this was maintained in 
metaphase II (I and J). All images are shown at 
the same magnification, bar = 10 m. 
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Figure 2.6. ORC4 translocates to the DNA during zygotic metaphase. ICSI generated zygotes were 
fixed and stained for ORC4 at different stages of zygotic metaphase. In zygotic metaphase, ORC4 is 
present in the nucleus of the second polar body (2nd PB) but not on the zygotic metaphase chromosomes 
(A-C). By early telophase, both sets of chromosomes are coated with ORC4 (D-F), and this persists to 
late telophase (G-I). All images are shown at the same magnification, bar = 10 m. 
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Figure 2.7. ORC4 is present in early G1 2-cell embryo nuclei.  ICSI generated 2-cell G1 embryos were 
fixed and stained for ORC4 and MCM7. In early 2-cell G1, ORC4 is detectable in both nuclei (A-D).  
Later in G1, MCM-7 is visible in both pronuclei, but ORC4 is absent (E-H).  The polar body (PB) 
retained ORC4, and did not accumulate MCM7. Insets show areas from different confocal planes than the 
rest of the figure. All images are shown at the same magnification, bar = 10 m. 
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Figure 2.8. Diagram of ORC subunit distribution during the first two cell cycles of the mouse 
embryo.  The distribution of the ORC subunits were determined in both this study and our previous 
publication for ORC2 (10). 
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CHAPTER 3. Higher Order Oligomerization of the Licensing ORC4 Protein is required 
for Polar Body Extrusion in Murine Meiosis 
3.1 Introduction 
 During mammalian, female meiosis, developing oocytes reduce the number of 
chromosomes to 1N by ejecting them in two polar bodies in a process called polar body 
extrusion (PBE) (57, 63). Polar bodies arise from asymmetric divisions in which most of the 
cytoplasm is retained in the oocyte (Fig. 3.1-1). To achieve this unequal division, actin filaments 
associated with Rab11 containing vesicles reposition the germinal vesicle chromosome plate to 
the cortex of the oocyte before cytokinesis (64, 65).  It is not clear how the set of chromosomes 
that will be ejected is chosen. In the first meiotic division, it could simply be the chromosomes 
that are more proximal to the cortex, but in the second division the metaphase plate is not 
originally aligned perpendicular to the oolema (56). Also, the oocyte is not simply discarding 
damaged DNA since it appears that the chromosomes in both the first or second polar body are 
intact because they can both be used to substitute for oocyte DNA and produce live pups in mice 
(66, 67).   
 We recently discovered an unexpected link between PBE and the DNA licensing protein 
ORC4 (17). ORC4 is one of six proteins that bind to DNA replication origins during the G1 stage 
of the cell cycle to establish the start sites for DNA synthesis (68). While the primary roles for 
the ORC proteins are well established to be in DNA replication, recent evidence suggests that 
many of them have additional functions that are related to the cell cycle, possibly to help 
coordinate the timing of DNA synthesis with other cellular processes (42, 51). While studying 
the roles of the six ORC proteins in early mammalian embryogenesis, we found that ORC4 
forms a cage that surrounds the set of chromosomes that will be extruded during anaphase in 
both meiotic divisions of murine oogenesis, but not around the set of chromosomes that remains 
in the oocyte (17) (Fig.1-1C & E). We termed this structure the ORC4 cage.  Here, we tested 
whether this ORC4 cage was required for PBE. We found that when the ORC4 cage formation 
was experimentally inhibited prior to second meiotic division, the oocytes did not extrude a 
second polar body. 
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3.2 Material and Methods 
3.2.1 Animals 
B6D2F1 mice obtained from National Cancer Institute (Raleigh, NC) were used as sperm 
and oocyte donors. Animal care and experimental protocols for handling and the treatment 
procedures were reviewed and approved by the Institutional Animal Care and Use Committee at 
the University of Hawai’i. 
3.2.2 Preparation of Spermatozoa and Oocytes   
Swim-up spermatozoa were prepared from the cauda epididymis as described (69). The 
spermatozoa suspension was used for intracytoplasmic sperm injection (ICSI).  Metaphase II 
(MII) oocytes were prepared from superovulated mice as described previously (10). Briefly, 
oviducts were removed 14 -15 hours after the injections of hCG and and the cumulus cells were 
released from the oviducts into 0.1% bovine testicular hyaluronidase in CZB (70) medium for 10 
minutes to disperse cumulus cells. The cumulus-free oocytes were washed and kept in CZB 
under a controlled environment (37ºC and 5% CO2).  
 To collect immature metaphase I and anaphase I oocytes, females were induced to 
superovulate by injections of 5 IU of eCG, as described (71). Oviducts were removed 48 hours 
after eCG injection and placed in HEPES-CZB (52) medium in a petri dish at room temperature.  
Germinal vesicle (GV) oocytes with surrounding cumulus cells were placed in CZB drops under 
mineral oil and cultured for 2 hours.  The oocytes that underwent germinal vesicle breakdown 
were collected and cultured for 4 and 9 hours to reach metaphase I and anaphase I, respectively. 
3.2.3 Intracytoplasmic Sperm Injection (ICSI) 
ICSI was carried out as described (52). Briefly, ICSI was performed using Eppendorf 
Micromanipulators (Micromanipulator TransferMan, Eppendorf, Germany) with a piezoelectric 
actuator (PMM Controller, model PMAS-CT150; Prime Tech, Tsukuba, Japan). After ICSI, 
oocytes were cultured in CZB at 37C under 5% CO2. 
3.2.4 Immunocytochemistry (ICC) 
 ICC was performed as described previously (10). Embryos were cultured in CZB until 
they reached the desired stage after ICSI or parthenogenesis activation, and fixed in 2% 
paraformaldehyde for 30 minutes at room temperature.  After fixing, cells were washed, blocked 
with 5% BSA for 1 h at room temperature, then incubated in primary antibody [Polyclonal goat 
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anti-ORC4 (L-15, catalog no. sc-19725 and C-15, catalog no. sc-19726; Santa Cruz 
Biotechnology, Santa Cruz, CA ), monoclonal mouse anti-HIS (catalog no. CGAB-HIS-0050; 
Genecopoeia) at 1:50 dilution overnight at 4C. The cells were washed again, then incubated in 
secondary antibody at 1:1500 dilutions at room temperature for 45 minutes. Cells were washed 
again, and mounted with ProLong Gold antifade reagent with DAPI (catalog no. P-36931; 
Invitrogen).  Images were collected on an Olympus FV1000 confocal microscope using 
Fluoview v. 2.1 software.   
3.2.5 mORC4-his tagged protein expression 
Recombinant plasmid containing hexahistidine (His6) tagged mORC4 (Genecopiea), with 
a T7 promoter, was transformed into E. coli (BL21(DE3)pLysS; Inivtrogen) to induce protein 
overexpression.  An individual colony of transformed E. coli plated on LB (containing 150 
µg/mL ampicllin and 35 µg/mL chloramphenicol) was picked to inoculate a 50 mL overnight 
culture (TB + Amp and chloraphenicol). After 18 hours 5 mLs of the overnight culture were 
added to 1 L of Terrific Broth (+150 µg/mL ampicllin and 35 µg/mL chloramphenicol). 
Induction of ORC4-his expression was started when the OD600 reaches 0.8 – 1.0. To induce 
protein expression, bacteria was cooled to ~18C, induced with 0.5 mM IPTG and incubated at 
room temp with 300 RPM shaking for 18h. Coomassie staining and western blot was used to 
monitor mORC4 expression and track purity of the sample following NiNTA and SEC 
purification.  
3.2.6 Microinjection of mORC4-his tagged protein into oocyte 
Recombinant mORC4-his6 protein was microinjected into the cytoplasm of MII oocytes, 
as described (72). In all experiments 10 pl of 1.8 µg/ml of peptide was injected into each oocyte. 
Following microinjection for different times, the oocytes were incubated in CZB free calcium 
medium contained 10 mM of SrCl2 with varying time points. ICC were used to visualize ORC4 
cage formation and overlap between His6 and endogenous ORC4 antibody staining. 
3.2.7 Induction of ectopic sperm polar body formation 
 Sperm were washed with 0.5% SDS for 1 min, then heated at 95C for 5 minutes, and 
finally incubated with Tx-100 for 10 minutes. A single SDS-washed, heated sperm head was 
picked up into the injection pipette.  An oocyte will be held to the holding pipette at the 9 o'clock 
position and then rotated until it reaches the metaphase II spindle. The prepared sperm head was 
redrawn into the pipette and microinjected immediately into the oocyte in the vicinity of the 
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membrane. Following ICSI, injected oocytes were cultured in CZB 37C under 5% CO2 in air 
for three hours and then activated with SrCl2 for desired time points (1h, 2h, and 3h, 
respectively). Phase microscopy and ICC were used to evaluate ORC4 cage formation. 
3.2.8 Brefeldin treatment of oocytes and embryos 
GV and MII oocytes were incubated with BFA (10 mM/ml) supplemented with 10 mM 
of SrCl2 at desired time points (12h and 2h or 5h, respectively) to inhibit polar body formation. 
All oocytes and embryos were incubated at 37C in a humidified atmosphere of 5% CO2 in air. 
3.2.9 Microinjection of Peptides into oocytes 
Six different peptides were injected into the cytoplasm of MII oocytes 1 hr before 
activation. In all experiments, 10 pl of 2.0 µg/µl RNA was injected into each oocyte. Following 
microinjection, the oocytes were incubated in CZB free calcium medium containing 10 mM of 
SrCl2 for one hour. Phase microscopy and ICC were used to evaluate polar body extrusion. 
3.2.10 mORC4-his Fragment Deletions 
mORC4-His6 plasmids were used to create assembly vectors by using NdeI and AvaI 
enzymes. Fragmented inserts with desired sequences were amplified by PCR reactions. The 
primers used to amplify the desired sequences included homology arms at the beginning and at 
the end of the assembly vectors. Gibson assay was then used to join vector and fragmented 
inserts together and the Gibson products were electrophoresed into bacteria.  Fragments were 
confirmed by single PCR colony and sequencing.  
3.2.11 mRNA synthesis 
 Plasmids containing the mORC4- and ORC4-His6 fragment mRNAs were linearized by 
an enzyme downstream of the ORC4 gene. mMESSAGE mMACHINE T7 transcription kit from 
Thermo Scientific was used to synthesize mRNA ORC4-His6 constructs. Agarose (1%) 
electrophoresis was used to confirm mRNA product, and isolate mRNA by Direct-zol RNA 
miniprep (Zymo Research). ORC4-His6 mRNA constructs were stored at -20°C prior to 
microinjection. 
3.2.12 Injection of mRNA 
Each ORC4-His6 mRNA constructs was used to microinject into the cytoplasm of MII 
oocytes. A microinjection volume of 10 pl/oocyte was used in all experiments. Following 
microinjection, the oocytes were incubated for 6 hours before parthenogenesis activation by 
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using CZB free calcium medium contained 10 mM of SrCl2 for three hours. ICC and Phase 
microscopy were used to visualize polar body extrusion.  
3.3 Results 
3.3.1 HIS-ORC4 Integrates Into the ORC4 Cage.  
We wished to first ascertain that the ORC4 cage, observed previously by our lab using 
ICC, truly contained ORC4 and was not an off-target effect of the antibodies (17). These 
experiments used two different commercial antibodies to identity ORC4 as a major component 
of the chromosome cage. We therefore made mouse ORC4 constructs with histidine tags for two 
variants of ORC4:  variant 1 that represents the full length version of ORC4, 433 amino acids in 
length (his-v1-mORC4) and variant 2 (73) that encodes the first 121 amino acids of the full 
length ORC4 (his-v2-mORC4). Both his-mORC4 transcripts were expressed in bacteria and the 
proteins isolated on a nickel column.  The purified protein, HIS-v1-mORC4 was electrophoresed 
and assayed with the ORC4 antibody we used for ICC and with an antibody to the HIS tag 
(Fig.2). The antibody we used for ORC4 ICC recognized a protein at an identical molecular 
weight as the antiHis ab, verifying that our prior ICC experiments  identified ORC4 (17). 
We next attempted to inject each variant into MII oocytes to determine if they become 
incorporated into the ORC4 cage as it forms after MII oocytes are activated. Our previous results 
demonstrated that the ORC4 cage is formed after metaphase is completed, during anaphase of 
both meiotic divisions (17). Oocytes were injected with our recombinant ORC4-His6 protein and 
stimulated to MII to examine if the His protein intergrates with native ORC4 in the cage 
structure. The full length, HIS-v1-ORC4 proved to be too difficult to solubilize for injections, 
but the smaller variant 2, HIS-v2-ORC4, could be injected. When oocytes were subsequently 
activated them with SrCl2 then stained with an antibody to the HIS-tag, we found that HIS-v2-
ORC4 did incorporate into the ORC4 cage (Fig. 3.3). This supported the conclusion that the 
DNA replication associated protein was part of the ORC4 cage that extruded chromosomes from 
the cytoplasm.  
3.3.2 A New ORC4 Cage Is Formed when the Oocyte Expels Sperm Chromatin 
The recruitment of ORC4-His6 to chromosomes during anaphase in meiosis suggests that 
ORC4 has a novel function associated with PBE. If so, the ORC4 cage should not be formed 
when PBE was inhibited, and, conversely, a new ORC4 cage should form if chromatin that was 
normally retained in the zygote was extruded. When we inhibited PBE with brefeldin A (BFA) 
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(20) (Fig. 3.4) or cytochalasin B (Fig. 3.5), parthenogenetically activated oocytes divided into 
two equal sized cells and no ORC4 cage was formed.  This suggested that the ORC4 cage was 
dependent on PBE. We then tested whether a second ORC4 cage formed if sperm chromatin was 
induced to be expelled at metaphase II. During normal fertilization the de-condensing sperm 
nucleus forms a “sperm cone” in which the oolemma around the sperm nucleus blebs outward in 
a manner similar to the initial stages of PBE (74,75)(Fig. 3.1-1E). This blebbing is normally 
resolved and the sperm chromatin is reabsorbed into the zygote. We never found an ORC4 cage 
around the sperm chromatin in normal fertilization (17) (Fig. 3.6A). The sperm cone, however, 
can be experimentally induced to form a complete vesicle that is ejected from the oocyte as an 
ectopic sperm pseudo polar body, similar to PBE (Fig. 3.6B&C). This occurs when sperm are 
washed with an ionic detergent and then injected into oocytes.  These sperm fail to activate the 
oocyte to complete its second meiotic division, but do begin to de-condense. When these 
fertilized oocytes are allowed to incubate for 3 hrs, then activated with SrCl2, the sperm 
chromatin is expelled as in a vesicle that resembles a polar body (26).  We repeated this 
experiment and found that a new ORC4 cage formed around the extruded sperm chromatin.  
ORC4 first localized at the oolemma near the decondensing sperm chromatin (Fig. 3.6B), then an 
ORC4 cage formed around the sperm chromatin (Fig. 3.6C). At G1, the sperm chromatin has 
been ejected as a pseudo polar body with an ORC4 cage (Fig. 3.6D). The ORC4 cage formed 
normally around the maternal chromatin that was extruded in the polar body in these oocytes. 
These data suggested that a second ORC4 cage forms around sperm chromatin when it is 
induced to be expelled by experimental manipulation. 
3.3.3 Disruption of the ORC4 Cage by ORC4 Peptides Prevents PBE 
The experiments above suggested that ORC4 cage formation is disrupted when PBE is 
inhibited, and that a new ORC4 cage can be induced to form around sperm chromatin when it is 
extruded from the oocyte.  This indicates that the ORC4 cage is associated with PBE, but does 
not prove it is necessary for PBE. We first attempted to test whether the ORC4 cage was required 
for PBE by disrupting it with siRNA to Orc4 but this had no effect, presumably because there 
was sufficient ORC4 protein present in the GV oocyte to construct the cage (17). Therefore, we 
disrupted the cage more directly using ORC4 peptides. We reasoned that the ORC4 cage 
required oligomerization, either ORC4 self-association or ORC4 interacting with another protein. 
We generated a putative three-dimensional structure for the full-length mouse ORC4 protein 
38 
 
using Phyre II software (Fig. 3.7) and identified six, 18 amino acid peptides that represented 
sequences of the protein that faced external surfaces that could be involved in protein-protein 
interactions to form polymers. The six peptides are shown in relation to the full length, v1-ORC4 
protein in Fig. 3.7. We note that no soluble peptides could be identified for one section of the 
ORC4 protein, between amino acids 210 and 340.   
Individual peptides were synthesized and injected into MII oocytes 1 hr before 
parthenogenetic activation. Four of the peptides that we injected, 6, 9, 14 and 16, had no effect 
on either the ORC4 cage or the production of the polar body (Table 3.1, Fig. 3.9), and were used 
as negative control samples in progressive experiments. Peptides 1 and 10, however, disrupted 
the ORC4 cage in anaphase II (Fig. 3.9B) or not to form at all (Fig. 3.9C) in many of the oocytes 
injected.  Injection of peptides 1 and 10 caused the parthenogenetically activated oocytes to 
produce two pronuclei (2 PN) within the oocyte rather than ejecting half of the chromosomes in a 
polar body in 27% and 13% of the oocytes, respectively (Table 3.1, Fig. 3.9D).  Peptide 1 proved 
to be much less soluble than peptide 10, so we were not able to inject as many oocytes with 
peptide 1, even though it appeared to be more effective. In all cases of 2 PN oocytes, there was 
no evidence of the ORC4 cage (Fig. 3.9D). When the ORC4 cage was disrupted by peptide 1 or 
peptide 10 injection, DNA synthesis still occurred, demonstrating that only one function of 
ORC4 was inhibited. These data suggested that the binding sites for ORC4 polymerization are 
close to the amino acid sequences that were in peptides 1 and 10. 
3.3.4 Disruption of the ORC4 Cage with ORC4 Fragments  
Injecting small, ORC4 peptides proved to be limiting because of solubilization problems.  
The solutions were viscous and sticky causing many of the injected oocytes to die.  Furthermore, 
it was possible that the sites on the ORC4 protein that were responsible for polymerization to 
form the ORC4 cage were larger than 18 amino acids, and larger peptides would have been more 
difficult to inject. We therefore created five ORC4 fragments that contained the gene sequences 
for ORC4 fragments that were 36 to 55 amino acids in length that included those of peptides 1, 
10 and 16 (Table 3.2). This was done by deletion mutation of the original murine v1-ORC4 
plasmid. The ORC4 fragments were inserted into expression plasmids and mRNA for each was 
synthesized. We also created mRNA for the v2-ORC4. To test our ability to inject intact mRNA 
into oocytes and that oocytes would generate protein from our mRNA, we first prepared and 
injected mRNA for GFP into MII oocytes and examined the oocytes by fluorescent microscopy 
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before and after parthenogentic activation. All oocytes fluoresced green indicating that MII 
oocytes are capable of synthesizing protein from mRNA.  Protein synthesis was evident before 
and after activation, and continued for up to 3 hrs after activation.   
 We next injected mRNA for the five ORC4 fragments we had created, and for the v2-
ORC4 variant into MII oocytes, and then parthenogenetically activated them. We found that v2-
ORC4, which was found to be incorporated into the ORC4 cage when injected as recombinant 
protein, caused the oocyte to produce two pronuclei instead of a polar body in 25.1% of oocytes 
(Table 3.2). Similar percentages of 2 PN oocytes resulted from the injection of the four ORC4 
fragment mRNAs that contained peptides 1 and 10. Only 3.9% of the oocytes injected with the 
control ORC4 fragment mRNA that contained peptide 16 progressed to 2PN. These differences 
were highly statistically significant (Tables 3.1&3.2). As with the peptide injections, in all cases 
of 2PN oocytes, there was no visible ORC4 cage.  
3.4 Discussion 
 Our previous work demonstrated that ORC4 forms a cage around the ejected 
chromosomes in both meiotic divisions (17). Here, we provide several lines of evidence to 
support our hypothesis that the ORC4 cage is required for polar body extrusion (PBE). First, 
when parthenogentically activated oocytes are induced to divide into two equal sized cells, rather 
than forming a polar body (Fig. 1-1B & D, Fig. 3.1-2), the ORC4 cage is no longer formed. More 
convincingly, when the sperm chromatin is induced to be extruded as pseudo-polar body, a new 
ORC4 cage is formed (Fig. 3.1-3E & F). Normally, the sperm chromatin which remains in the 
oocyte is not associated with an ORC4 cage (Fig. 3.1-3). The fact that the ORC4 cage forms 
around the sperm chromatin suggests that it is clearly associated with extrusion of the chromatin.  
 The most direct evidence that the ORC4 cage is required for PBE is that ORC4 peptides 
and ORC4 fragments that were injected into the oocyte prevented the formation of the ORC4 
cage, and when this happened both maternal sets of chromatin were retained within the oocyte, 
rather than one being ejected in a polar body (Fig. 3.9, Tables 3.1&3.2). As discussed above, the 
premise for this experiment was that peptide fragments that contained ORC4 sequences would 
inhibit the polymerization of ORC4 that is required to form the cage. We focused on MII oocytes 
rather than GVBD oocytes because the ORC4 cage does not form until after activation, so we 
could inject the peptides before the cage was formed. MII oocytes are also stronger and survive 
injection more easily. The peptide sequences that were chosen were based on a putative ORC4 
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3D structure (Fig. 3.7), but the results do not depend on the accuracy of this particular structure.  
We found that of the six peptides we tested, only two prevented ORC4 formation and caused the 
oocyte to retain both sets of chromatin producing two pronuclei (2 PN) rather than the normal 
one pronucleus and one polar body (1PN + PB) (Table 3.1).  Because the other four peptides 
were also ORC4 sequences, they served as good controls for this experiment.  These experiments 
specifically targeted the ORC4 cage, and this disrupted PBE, demonstrating that the ORC4 cage 
is required for PBE.   
 Two areas of ORC4 appeared to be involved in oligomerization, as judged by their ability 
to prevent ORC4 cage formation, the sequences defined by peptides 1 and 10 (Fig. 3.8).  Neither 
peptide, nor the larger versions of these sequences that were injected as mRNA, were able to 
inhibit PBE all of the time, but the percentages of 2PN parthenogenetically activated oocytes that 
were formed (13% to 27%) were all very statistically different from controls (Tables 3.1 & 3.2).  
There are many possible reasons for this, including the stability of the peptides injected, the limit 
on the amount of peptide or mRNA that could be injected, and the efficiency of the peptides and 
ORC4 fragments to inhibit the cage. When we attempted to lengthen the ORC4 domain that 
inhibited cage formation with mRNA, we did not increase the percentage of oocytes that 
developed to 2 PN for peptide 1. For peptide 10, however, increasing the number of amino acids 
from 18 to 46 increased the percentage of 2 PN oocytes from 13% to 25%, a statistically 
significant increase (p = 0.005, Table 3.1 & 3.2). This suggests that at least one of the putative 
polymerization domains for ORC4 is larger than 18 AA.  It is clear that of the six areas of the 
ORC4 protein that were injected, two of them were able to prevent ORC4 cage formation and in 
every instance that the cage was inhibited, so was PBE.   
 One interesting apparent paradox in the data may provide some insight into how the 
ORC4 cage is formed.  One would expect that the ORC4 cage which is a three dimensional 
sphere (17), would include not only simple polymerization but some kind of branching to link 
the polymers. We showed that HIS-v2-ORC4 becomes part of the ORC4 cage (Fig. 3.3) but 
excessive amounts of this ORC4 variant can also prevent its formation (Table 3.2). One 
explanation for these results is that v2-ORC4 plays a role in branching to form the cage, but too 
much will prevent the cage from forming by recruiting all the available full length v1-ORC4 for 
branching instead of polymerization. 
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 The more usual function of ORC4 is to participate in the ORC complex that identifies 
origins of replication (14, 41). ORC4 is part of the core that forms the ORC (48), and it binds 
directly to DNA and can form non-canonical structures with DNA (16, 76). ORC4 exists in the 
cytoplasm before it forms the ORC (48), so its presence in the cytoplasm of the oocyte (17) is 
consistent with its behavior in somatic cells.  It is possible that the sequestration of ORC4 in the 
ORC4 cage also functions to delay DNA replication during the two mitotic divisions of the 
meiotic oocyte. There is also an accrual of ORC1, ORC2, ORC3 and ORC5 in the area between 
the separating chromosomes at anaphase I and anaphase II in oogenesis (10, 17) that may serve a 
similar function.  The ability of ORC4 to bind directly to DNA, itself, may contribute to the 
formation of the ORC4 cage that coats the extruded chromatin.  It is also possible that ORC4 
cage formation participates in asymmetric divisions of other cell types and in the extrusion of 
chromatin from developing erythroblasts (77, 78).   
 This work demonstrates that the DNA licensing protein ORC4 forms a large cytoplasmic 
structure, the ORC4 cage that is required for PBE.  This is the first example of a functional 
structure formed by the ORC proteins. Current work is focused on understanding the 
mechanisms of how the ORC4 cage coordinates PBE and DNA replication. 
3.5 Contributions 
Research design: Hieu Nguyen, Nicholas Grant James, David M. Jameson, Michael A. Ortega, 
and W. Steven Ward. 
Conducted experiments: Hieu Nguyen, Nicholas G. James, Lynn Nguyen, Thien P. Nguyen, and 
Cindy Vuong. 
Contributed to writing: Hieu Nguyen, Nicholas G. James and W. Steven Ward. 
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Figure 3.1: Diagram of ORC4 in mouse early embryonic development. (1) Normal fertilization: 
ORC4 is present in the cortex of GVBD oocytes (A), and coalesces near the chromosomes in metaphase I 
(B). ORC4 forms a cage around the chromosomes that are ejected in the first (C, D) and second (E, F) 
polar bodies. (E) The sperm chromatin forms a “sperm cone” which can be thought of as an abortive polar 
body that is reabsorbed by the oocyte by G1. (2) parthenogenesis: ORC4 behaves the same way in 
parthenogenetically activated oocytes. BFA treatment of metaphase I (B) and metaphase II (D) oocytes 
results in the oocytes dividing into two equal sized cells and no polar body. The effects of BFA and 
Peptide injection are also shown. (3) Delayed activation: Detergent washed sperm do not activate oocytes 
when injected. If activation by SrCl2 is delayed, the sperm chromatin is surrounded by ORC4 and ejected 
as a pseudo-polar body (F). 
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Figure 3.2: Confirmation of Antibody Recognition of ORC4. The his-v1-mORC4 transcript was 
expressed in bacteria and the protein isolated on a nickel column, then by size exclusion chromatography 
(SEC).  Fractions from the final SEC column are shown below. The isolated HIS-v1-ORC4 was analyzed 
by western blot using the antibody for ORC4 (C-15 from Santa Cruz Biotechnology) used in this study. 
The isolated HIS-v1-ORC4 was recognized by the antibody (lane 7). Lane 1, post induction fraction; lane 
2, void volume (~90 mLs);  lane 3, peak at 120 mLs;  lane 4, peak at 130 mLs; lane 5, peak at 150 mLs; 
lane 6, peak 170 mLs; lane 7, 205 mLs (~ 47 kDa MW based on calibration of the column).  
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Figure 3.3. Incorporation of v2-ORC4-HIS6 into the ORC4 cage. Purified v2-ORC4-HIS6 protein was 
injected MII oocytes prior to activation. The oocytes were developed to G1 with the second polar body, 
then fixed and immunostained for ORC4 (green), and for the Histidine tag (red). The figure showed 
confocal sections of one oocytes with filters for DAPI (A), ORC4 (B), His-tag (C), and merge (D). Imaris 
software was used to identify where the v2-ORC4-HIS6 was localized (E and F). Bar =10 um. 
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Figure 3.4. Effect of Brefildin A (BFA) on Polar Body Extrusion and ORC4 Cage Formation. MII 
oocytes were treated with Cytochalasin B (10 µg/ml) for 2 hrs, then activated with SrCl2 in the presence 
of 10 µM EdU.  The parthenogenetically activated oocytes were then incubated for up to 24 hrs, then 
stained for ORC4 and EdU incorporation.  No ORC4 cages were formed (data not shown). At 8 hrs post 
activation, two pronuclei were formed inside the oocyte (A, B) and EdU staining indicated that DNA 
synthesis was not inhibited. By 24 hrs, the oocyte had four pronuclei that were all positive for EdU 
staining, suggesting that even though cytochalasin B inhibited polar body extrusion and oocyte 
cytokinesis, DNA synthesis and nuclear division was not. This supports the different roles of ORC4, one 
in DNA synthesis and one for DNA replication. 
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Figure 3.5. Effect of Cytochalasin B on Polar Body Extrusion and ORC4 Cage Formation. MII 
oocytes were treated with Cytochalasin B (10 µg/ml) for 2 hrs, then activated with SrCl2 in the presence 
of 10 µM EdU. The parthenogenetically activated oocytes were then incubated for up to 24 hrs, then 
stained for ORC4 and EdU incorporation.  No ORC4 cages were formed (data not shown).  At 8 hrs post 
activation, two pronuclei were formed inside the oocyte (A, B) and EdU staining indicated that DNA 
synthesis was not inhibited.  By 24 hrs, the oocyte had four pronuclei that were all positive for EdU 
staining, suggesting that even though cytochalasin B inhibited polar body extrusion and oocyte 
cytokinesis, DNA synthesis and nuclear division was not. This supports the different roles of ORC4, one 
in DNA synthesis and one for DNA replication. 
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Figure 3.6.  A New ORC4 Cage Forms with Ectopic Sperm Pseudo Polar Bodies. (A) Confocal image 
of a normal ICSI fertilized oocyte at anaphase II. The ORC4 cage surrounds the maternal chromosomes 
that will be extruded, and the DNA in the first polar body (lower inset).  The sperm chromatin is devoid 
of ORC4 cage (upper inset). (B-D) An embryo injected with a detergent washed spermatozoa and 
activated 2 hrs later. (B) The delayed embryo in metaphase II before activation. ORC4 begins to 
accumulate at the oolemma new the decondensing nucleus. Tubulin (red) accumulates around the poles of 
the chromatin mass. (C) By anaphase II, ORC4 has completely surrounded the sperm chromatin. (D) At 
G1, the sperm of the delayed activated zygote has been ejected into an ectopic pseudo polar body in 
which the chromatin is surrounded by an ORC4 cage. Bar = 10 µm.   
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Figure 3.7.  Putative 3D Structure of Murine ORC4.  Using the Phyre2 software 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index) we generated a predicted 3D model for the 
full length murine v1-ORC4 protein.   The position of the six peptides used in this study are shown. 
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Figure 3.8. ORC4 peptides and fragments. The full-length version 1 ORC4 with 433 amino acids is 
shown in relation to the six peptides and five ORC4 fragments used in this study. The peptides are shown 
in blue (peptides with no effect on PBE) and red (the two peptides that prevented PBE). The positions of 
the five ORC4 fragments that mRNA sequences used in this study coded for are shown in purple. 
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Figure 3.9. Injection of ORC4 peptides disrupts ORC4 cage and inhibits PBE. MII oocytes were 
injected with ORC4 peptides 1 hr before parthenogenetic activation. The oocytes were stained at 
anaphase II or G1 for ORC4. (A) An oocyte with peptide 1 that formed a normal ORC4 cage at anaphase 
II. (B) An oocyte with the ORC4 cage didrupted at anaphase II. (C) An oocyte with peptide 1 with no 
visible ORC4 cage. (D) An oocyte injected with peptide 1 that did not extrude a polar body. Both 
maternal sets of chromosomes formed pronuclei. Some ORC4 staining was visible at the cortex. (E) An 
oocyte injected with peptide 1 that formed a normal polar body with an ORC4 cage. (F) An oocyte 
injected with control peptide 16 that progressed to PBE. Oocytes were stained with an antibody for ORC4 
(green) and DAPI (blue. Bar=10mM). 
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Peptide 
AA Position in 
ORC4 
No. Oocytes 2 PN 
1 12 to 29 68 15 (22.1%)*  
6 102 to 119 122 0  
9 138 to 155 96 0 
10 191 to 208 139 16 (11.5%) 
14 352 to 369 123 2 (1.6%) 
16 382 to 399 88 2 (2.3%)  
 
Table 3.1. Injection of ORC4 Peptides. Peptides were injected into MII oocytes before parthenogenetic 
activation. The percentages of oocytes that progressed to having two pronuclei (2 PN) instead of the 
normal development to one PN and a polar body, are shown. For each peptide, at least two independent 
experiments were performed. There was no statistically significant difference between the individual 
experiments within each peptide, or between peptides 6, 9, 14 and 16 using, using the Fisher’s Exact Test 
(p < 0.05). There was no statistical difference between peptides 1 and 10, but both were statistically 
different from all other peptides. All p values are listed in Table 1. 
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ORC4 Frag 
AA Position in 
ORC4 
No. AAs 
No. 
Oocytes 
2 PN 
v2-ORC4 1 to 121 121 128 32 (25%)* 
Peptide 1 12 to 47 36 120 32 (26.7%) 
Peptide 1 Lg 2 to 47 46 152 40 (26.3%) 
Peptide 10 190 to 235 46 158 29 (18.4%) 
Peptide 10 Lg 180 to 235 55 140 35 (25.0%) 
Peptide 16 374 to 413 40 127 5 (3.9%) 
 
Table 3.2.  Injection of mRNA for ORC4 Fragments. mRNA for five different ORC4 fragments were 
injected into oocytes before parthenogenetic activation, and the progression to 2 PN was assessed. For 
each ORC4 fragment mRNA that was injected, two experiments were performed. There was no statistical 
significantly difference between experiments for each peptide, or between v2-ORC4, Peptide 1, Peptide 1 
Lg, Peptide 10, or Peptide 10 Lg. Peptide 16 was highly statistically significant for all other peptides. All 
p values are listed in Table 2. 
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CHAPTER 4: Spatial and Temporal Resolution of ORC4 Fluorescent Variants Reveals 
Structural Requirements for Maintaining Higher Order Self-association and Pronuclei 
Entry  
4.1 Introduction 
The combined results from Chapters 2 and 3 provide evidence that ORC4 has a role 
outside of DNA licensing, namely that ORC4 undergoes large scale reorganization from the 
plasma membrane to self-association into a cage-like structure that surrounds chromosomes 
destined for extrusion. The essential regions required for higher order cage formation were 
identified as the N-terminus and the middle domain through injection of peptides designed to 
occupy surface exposed regions of ORC4 (Chapter 3). Injection of embryos with peptide 
sequences from amino acids 12 - 29 and 191 - 208 were found, via immunocytochemistry, to 
prevent ORC4 cage formation whereas peptides designed from other regions (such as 102 - 119 
and 138 - 155) failed to prevent ORC4 self-association. Inhibiting the higher order assembly of 
ORC4 was found to prevent PBE resulting in injected embryos forming 2 pronuclei (PN) during 
maturation instead of dividing into two cells (79). Interestingly, prevention of higher order 
ORC4 complex formation did not disrupt licensing for DNA replication. This demonstrates that 
the dichotomy functions ascribed to ORC4 within embryos are not mutually exclusive and, thus, 
likely involve interactions within different regions of the protein.    
While our results have provided a unique look at ORC4 activity during oocyte 
development and identified its role in PBE, we are still missing critical events associated with the 
dynamic switch in function of ORC4 during oocyte activation. Advance fluorescence 
methodology like Fluorescence Lifetime Imaging (FLIM) has been previously utilized to track 
the activity of proteins down to the low nanomolar concentration and, therefore, could be utilized 
for providing methods to track ORC4 dynamics in live embryos (80), (81), (82). Fluorescence is 
a process whereby light is emitted from a molecule subsequent to absorption of light. Absorption 
of a photon promotes a ground-state electron, typically from a π orbital, to an excited state 
wherein it will relax down to the lowest vibrational level within the lowest excited state. The 
electron will then remain in the excited state for a period of time, at which point it will return to 
the ground state and emit a photon of light (i.e. fluorescence). The average time in which the 
electron remains within the excited state is called the lifetime (83). This property is unique 
among each fluorophore and is often times obtained using time- or frequency domain 
measurements.  
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Excited state lifetime measurements are powerful as they can provide unique information 
about the molecular environment that is not observed from intensity measurements. To obtain a 
quantitative lifetime values requires fitting the time-resolved data, obtained using the methods 
mentioned above, to a model until the best is obtained as determined via reduced χ2 value. 
Simple decay, such as obtained for the fluorophore fluorescein in a basic solution, is straight 
forward and can often times be modeled using a single exponential decay. Heterogeneous 
emission requires more complex analysis, such as multiple exponential models. However, this 
type of analysis is only able to resolve multiple components when your sample has high emission 
(<2000 counts). The lifetime data was converted to a phasor plot to determine temporal property 
of each fluorophore tested. Lifetime measurements have become popular in microscopy as it can 
provide a spatial and temporal map thus detailing organization of fluorophores within a cell and 
alterations in microenvironment. One difficulty in this is the lack of counts per pixel. Therefore, 
extraction of lifetimes requires significant statistical analysis to obtain average lifetime values. In 
1984, a model-less method of analysis was introduced, called the phasor plot, which has gained 
popularity among microscopist as it only requires the raw data. The phasor analysis graphical 
representation where the modulation is a vector with an angle equal to the phase delay (83). The 
x and y coordinates of the vector derive from: x = G = Mcosϕ; y = S = Msinϕ. For a single 
exponential decay, this vector describes a semicircle which is referred to as the universal circle. 
Single fall on it. Complex decays fall inside the universal circle. Thus able to graphically 
represent complex decay emission and spatially separate components within a sample on the 
phasor plot (Fig. 4.1). In this section of the dissertation, we constructed fluorescent variants of 
ORC4 generated by fusing it to a fluorescent protein (FP), enhanced green fluorescence protein 
(eGFP), as well as a variant containing a unique amino acid sequence for site-specific labeling. 
eGFP is a ~ 26 kDa protein that displays green fluorescence when it is excited with blue light 
(84). It has been shown that ORC fusion with GFP at either N- or C-termini, retain their DNA 
replication function (2). However, we cannot predict how fusion of eGFP onto ORC4 will affect 
its function(s) in oocytes as the addition of this protein will increase the total mass to 158% of 
the original construct. We have also generated an ORC4 containing a FlAsH sequence inserted 
within the C-termini as a means to circumvent these potential issues from the eGFP fusion 
construct.  FlAsH-EDT2 is a derivative of fluorescein and used in site-specific labeling of 
proteins in live cells wherein it binds with high affinity to proteins containing the tetra-cysteine 
55 
 
motif cys-cys-pro-gly-cys-cys (85), (86) (Fig. 4.5). FlAsH-EDT2 is cell membrane permeable 
and is smaller than 1 kDa (87) compared to eGFP (26 kDa) and would therefore not be expected 
to cause large perturbations within the protein due to the significantly smaller mass increase. 
Herein we demonstrate the injection of mRNA of each fluorescent variant of ORC4 can provide 
a unique signal allowing for the quantification of ORC4 dynamics at different stages of oocyte 
activation. Lifetime imaging indicates the licensing function has probably not been altered for 
both constructs as each variant could be spatially resolved within the PN. Furthermore, we 
provide compelling evidence that the ORC4-FlAsH variant can be recruited to the ORC4 cage 
during PBE and was shown to be consistently associated with PB. These results demonstrate that 
fluorescent variants of ORC4, specifically those labeled with small molecules, could be useful 
for future single molecule dynamic studies for ORC4. 
4.2 Materials and Methods  
4.2.1 Animals  
Eight-week of age mice, B6D2F1 (C57BL/6N X DBA/2), were used.  Mice were 
obtained from National Cancer Institute (Raleigh, NC), and used at 8 – 12 weeks of age. Animal 
care and experimental protocols for handling and the treatment procedures were reviewed and 
approved by the Institutional Animal Care and Use Committee at the University of Hawai’i. 
4.2.2 Creating the orc4-egfp construct 
mORC4 variant 1 plasmids (full length of orc4) bought from genecopoeia were used to 
create assembly vectors by using AvaI enzyme. eGFP sequences was amplified by PCR 
reactions. The primers used to amplify the eGFP sequences included homology arms at the 
beginning and at the end of the assembly vectors. Gibson assembly was then used to join vector 
and eGFP together and the Gibson products were electrophoresed into bacteria.  The orc4-egfp 
constructs were confirmed by single PCR colony and sequencing.  
4.2.3 Creating the construct of orc4 for FlAsH labeling 
mORC4 variant 1 plasmids (full length of orc4) bought from genecopoeia were used to 
create a mutation construct containing six-amino acid sequences (Cys-Cys-Pro-Gly-Cys-Cys). 
First, we deleted six amino acids at amino acid number 407- 412 and replaced them with Cys-
Cys-Pro-Gly-Cys-Cys sequences by using Gibson. The mutation products were confirmed by a 
single PCR colony and sequencing. 
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4.2.4 mRNA-ORC4-eGFP synthesis 
Plasmids containing the mORC4- eGFP and ORC4-FlAsH mutation constructs were 
linearized by an enzyme downstream of the ORC4 gene. mMESSAGE mMACHINE T7 
transcription kit from Thermo Scientific was used to synthesize mRNA ORC4-eGFP constructs. 
Agarose (1%) electrophoresis was used to confirm mRNA product, and isolate mRNA by Direct-
zol RNA miniprep (Zymo Research). ORC4-eGFP mRNA constructs were stored at -20°C prior 
to microinjection. 
4.2.5 Injection of mRNA-eGFP 
Each ORC4-eGFP mRNA and ORC4-FlAsH mutation constructs were used to 
microinject into the cytoplasm of MII oocytes. A microinjection volume of 10 pl/oocyte was 
used in all experiments. Following microinjection, the oocytes were incubated for at least 4 hours 
and checked for eGFP signal under microscope. When eGFP signal expressed on oocytes, we 
activated oocyte development via parthenogenesis activation by using CZB free calcium medium 
contained 10 mM of SrCl2 for two hours (AII) and three hours (G1). These AII and G1 embryos 
were imaged and tracked eGFP movement by using fluorescence microscopy.  
4.2.6. FlAsH labeling 
After microinject mRNA-ORC4 mutation containing of the Cys-Cys-Pro-Gly-Cys-Cys 
amino acids for at least 4 hours before parthenogenesis activation injected oocytes to develop AII 
and G1 stages. Solid FlAsH-EDT2 was provided by Dr. Nicholas James. Following 
microinjection, the oocytes were incubated with SrCl2 2 hours and 3 hours for anaphase II and 
G1, respectively. Activated oocytes were then incubated with FlasH-EDT2 for 30 minutes. Next, 
the activated oocytes were washed with EDT + DMSO and PBS + glucose to remove FlAsH. 
The activated oocytes labeled with FlAsH were analyzed with a confocal fluorescence 
fluctuation spectroscopy. 
4.2.7. Dynamics of fluorescent ORC4 in Oocytes  
Confocal fluorescence fluctuation spectroscopy (FFS) measurements were recorded on an 
Alba fluorescence correlation spectrometer (ISS, Champaign, IL), equipped with x-y scanning 
mirror, connected to a Nikon TE2000-U inverted microscope (Nikon, Melville, NY) with a 
PlanApo VC 60 x 1.2 NA water objective.  Two-photon excitation of enhanced eGFP was 
provided by a Chameleon Ultra (Coherent, Santa Clara, CA) tuned to 920 nm with < 1 mM laser 
power.  Fluorescence emission was collected through a 535/50M bandpass filter (Chroma, 
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Bellows Falls, VT) in front of a photo multiplier detector (H7422P-40, Hamamastu, Hamamastu 
City, Japan). Cells were imaged in a humidified enclosed chamber kept at 37ºC (Tokai Hit, 
Fujinomiya, Sizuoka, Japan). An objective heater wrapped round the neck of the objective was 
used to minimize temperature drifts (with a 20 minute delay to equilibrate the temperature prior 
to imaging) and the collar of the objective was adjusted to compensate for temperature and 
thickness of the coverslip.   
Diffusion and concentration of ORC4 constructs was determined using Raster Imaging 
Correlation Spectroscopy (RICS) (85). Briefly, 12.8 micron (50 nm pixels) regions of interest 
were selected from the fluorescence image. The pixel sampling time was 12.5 μs, each frame had 
256 x 256 pixels, and each measurement lasted ~ 1 min (100 frames). The beam waist (ω0) 
calibration was achieved by measuring the autocorrelation curve of fluorescein (~ 20 nM) in 0.01 
M NaOH, and fitted with a diffusion rate of 430 µm2/sec, which were performed before each 
day’s measurement (85). The typical values of ω0 were at the range of 0.35 – 0.4 µm. 
FLIM (Fluorescence-lifetime imaging microscopy) measurements were recorded through 
an ISS A320 Fast FLIM box coupled to the Ti:Sapphire laser, which produces 80-fs pulses at a 
repetition rate of 80 MHz, and photo multiplier detector (H7422P-40, Hamamastu, Hamamastu 
City, Japan).  Fluorescein, which was used as the lifetime reference (4.0 ns), and FlAsH was 
excited at 780 nm and the fluorescence signal was filtered away from excitation light through a 
520 nm bandpass filter (FF01-520/35; Semrock Rochester, NY) mounted in front of the detector.   
4.3. Results:  
4.3.1 Biophysical Characterization of ORC4-eGFP 
Oocytes injected with mRNA ORC4-eGFP were observed to have a homogenous 
distribution, including in the PB, of fluorescence during all activation stages imaged (Fig. 4.2). 
The movement of ORC4-eGFP was analyzed using a technique called fluorescence-lifetime 
imaging microscopy, or FLIM. FLIM provides a pixel analysis on the lifetime of the fluorescing 
species; thus allowing for the resolution of pixels that contained eGFP versus autofluorescence. 
FLIM was recorded for each oocyte. FLIM data were analyzed by a mathematical process 
termed FLIM-phasor, which calculates the shift in wavelength between the excitation and 
emission signals, and the intensity of the fluorescent signal. FLIM-phasor is a modeless plot 
wherein the phase shift and demodulation (raw data) are plotted on X (G) and Y (S) coordinate 
system. Signals from eGFP have a known phasor point based on the lifetime of the fluorophore 
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(~ 3 ns), while background “autofluorescence” is composed of a more complex mixture of 
molecules. As such, eGFP phasor points should lie near the arc, or universal circle, of the FLIM-
phasor analysis (Fig. 4.2D; Table 4.1).  
FLIM-Phasor analysis of ORC4-eGFP injected oocytes showed phasor points that were 
shifted inside the universal circle indicating a more complex lifetime compared to non-fused 
eGFP injected into oocytes (Fig. 4.2D). This suggests that ORC4 alters eGFP fluorescence or 
that the fusion proteins interact with the same result. Nearly all images collected contained a 
large number of pixels within the autofluorescence region when injected with the ORC4-eGFP 
variant. The majority of oocytes analyzed (No 6/10) were found to have pixels within their PBs 
that corresponded to the autofluorescence region (Fig. 4.3). Essentially, ORC4-eGFP was 
prevelant throughout the oocyte with no visible accumulation at any site. The phasor points of 
ORC4-eGFP showed no major changes in location at different stages of oocyte activation. 
However, phasor points associated with the PN at zygotic G1, though very low in intensity, were 
found to be shifted more towards the universal circle than ORC4-eGFP throughout the embryo, 
suggesting that PN ORC4-eGFP was closer to that of free eGFP. This suggests that ORC4 
proteins in the PN have a different protein-protein interaction than those in the cytoplasm (Fig. 
4.3).     
The dynamics of ORC4-eGFP were determined by analyzing fluctuation data collected 
from oocytes containing a strong signal from eGFP. RICS (Raster imaging correlation 
spectroscopy) analysis, which allows for a spatial observation of molecular fluctuations, 
produced an average diffusion of ORC4-eGFP of 5.0 ± 0.5 μm2/sec. This rapid speed usually 
indicates untethered, soluble proteins. Visual inspection of the collected frames indicated that the 
diffusion might be more complex as we observed areas containing large fluorescent spots (Fig. 
4.5A and 4.5B).  Analysis of regions containing these spots produced diffusion values that were 
~ 10x slower than regions containing no spots (0.8 ± 0.3 vs. 7.5 ± 1.0 μm2/sec). These data 
suggest that there are two populations of ORC4-eGFP in the cytoplasm, a rapidly moving, 
untethered population and another one that is self-associated, moving more slowly. These results 
are in line with our observation that ORC4 can self-associate.  However, we were unable to 
observe large self-association, like cage formation, from the fluorescence signal during PB 
formation and the FLIM-phasor analysis did not identify spatially resolved structures for ORC4-
eGFP.  
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4.3.2 Biophysical Characterization of ORC4-FlAsH  
The lack of ORC4 cage appearance from our eGFP fusion construct suggests that this 
modification may have limited ORC’s ability to self-associate; potentially inhibiting it from 
recruitment during cage formation. Therefore, we created a mutated protein, ORC4-FlAsH, that 
has no additional amino acids and only has six amino acids substituted in an alpha-helix portion 
of the protein.  These include four cysteine residues that interact with a compound, EDT2, to 
generate a fluorescent signal in cells (Fig. 4.6). We characterized the dynamics of ORC4-FlAsH, 
which was fluorescently labeled after the protein was produced by the embryo using the site-
specific FlAsH-EDT2 compound, to determine if we could obtain better spatial resolution of 
ORC4.  Non-mRNA injected embryos that were treated with FlAsH-EDT2 showed a high 
number of pixels with phasor points similar to the unbound fluorophore (Fig. 4.7A and B).  
Nevertheless, we were able to detect some accumulation of ORC4 in the area where we expected 
to see the ORC4 cage (Fig. 4.7C). Note the total fluorescence was low, but the excited state 
properties that were determined by FLIM were indicative of FlAsH as compared to 
autofluorescence.  This indicated that our washing protocol was not fully effective at removing 
non-specific bound FlAsH-EDT2; however, we were unable to modify the current protocol due to 
the sensitivity of the embryos to the wash conditions.  FLIM-phasor analysis of embryos injected 
with ORC4-FlAsH mRNA, and treated with the FlAsH-EDT2 compound, produced phasor points 
that were shifted away from the non-specific bound phasor points (Fig. 4.8B). These results are 
in line with previous reports that observed modified fluorescent properties of this fluorophore 
when bound to the FlAsH sequence (86). Even though they were off the universal circle, they 
appear closer to the expected FlAsH phasor point than autofluorescence signal. Therefore, the 
use of FLIM-phasor analysis allowed us to resolve non-specific versus specific binding of 
FlAsH-EDT2 within the embryos. For our experiments we only used embryos with the majority 
of their phasor points associated with ORC4-FlAsH.  We also note that there were fewer phasor 
points in the autofluorescent region when working with ORC4-FlAsH compared to ORC4-eGFP.    
Intensity images of ORC4-FlAsH (Fig. 4.7A) showed non-homogenous emission 
distribution throughout the embryo, unlike ORC4-eGFP, with intensity patterns also being 
observed in the PB (Fig. 4.5B and C).  Images appeared to have bright decorations along the 
plasma membrane and distinct circular, or cage like, structures near the plasma membrane during 
PBE (Fig. 4.7C), which is in line with previously characterized spatial organization of ORC4 
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(79).  Fluctuation analysis produced nearly identical diffusion properties as our ORC4-eGFP 
construct (average diffusion 6.0 ± 1.0 μm2/sec; individual components 7.0 ± 0.8 and 0.6 ± 0.2 
μm2/sec). The concentration of ORC4-FlAsH, which was determined by analysis of the 
autocorrelation function was found to be higher (160 ± 50 nM) than the eGFP variant (40 ± 10 
nM) from our sampled embryos (n = 10).  This variation might be caused from alterations in the 
actual amount of mRNA injected into each oocyte or might indicate alterations in protein 
production/degradation for each construct.  Much like ORC4-eGFP, the phasor points of ORC4-
FlAsH were slightly shifted within the PN, as well as around the PM, compared to the points that 
resolved ORC4-FlAsH with the embryo.  These correlated results are indicative that these 
constructs are not excluded from the PN and that licensing from both variants likely still occurs.    
4.4 Discussion  
Herein we present a study aimed at characterizing the dynamics of ORC4, following cage 
formation up to PBE, in live, activated oocytes using advance fluorescence microscopy.  
Fluorescence methodologies are extremely sensitive which can allow for the examination of 
target molecules down to the single molecule level (87), (88).  However, this sensitivity can only 
be achieved in systems that contain a bright signal above the background.  In the case of cells 
there is always contaminating emission from the system, or autofluorescence, and it is critical to 
not only minimize this signal but also to confirm that the origin of emission being reported is in 
fact associated with the molecule of interest (89), (90).  Our system, activated oocytes, are highly 
dynamic cellular systems that undergo large fluctuations in proteins and membranes (79). As 
expected from such a complex system, we observe a large amount of autofluorescence signal 
even when exciting with an infrared laser. Therefore, time resolved measurements were 
prioritized over intensity-based measurements as we were uncertain to the amount of signal that 
would be originating from ORC4-eGFP or ORC4-FlAsH compared to the embryo 
autofluorescence.  Using FLIM-phasor analysis we were able to spatially resolve the lifetime of 
our fluorescent markers, both eGFP and FlAsH, from the autofluorescence signal thus allowing 
for the resolution of ORC4 protein in live oocytes during different states of maturation (Fig. 
4.2A and 4.7A).  To simplify our interpretation, sample analysis was constrained to embryos 
wherein the majority of phasor points (> 90) were originating from our fluorescent molecule.   
The essential questions that we sought to address within this study were: 1) does 
modification of ORC4 at the C-terminus, with eGFP or the FlAsH sequence, alter its activity? 
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and 2) could we observe cage formation and PBE with either of these constructs? Our 
experiments demonstrated that activated embryos that were injected with our mRNA could still 
undergo PBE and division.  Each embryo tested contained endogenous ORC4 which makes it 
difficult to make any conclusive statements regarding the functionality of these variants towards 
development. As such, we focused on known biophysical properties and qualitative 
characterization from confocal imaging.  For example, our model of ORC4 cage formation 
predicts higher order self-association of ORC4 and we should be able to quantify this via 
diffusion characteristics of labeled ORC4. Our fluctuation data yielded multiple rate constants: ~ 
6 and ~ 0.5 μm2/sec to which we assign the monomer form and to a self-associated state of 
ORC4, respectively; demonstrating self-association can occur with both variants.  The lack of 
spatial resolution of higher order self-association of ORC4-eGFP (i.e. no visualization of a cage 
at any stage of activation) is indicative that this variant is not recruited for chromosome selection 
nor involved in PBE.  Further evidence of this lack of higher order assembly for ORC4-eGFPs is 
the non-essential requirement of eGFP and lack of structured emission from within the PB 
whereby only 40% of cells examined contained eGFP within the PB (Fig. 4.1C and D).  
Therefore, we speculate that the addition of eGFP at the C-termini introduces steric hindrance on 
higher order ORC4 structure formation thus preventing this variant from being tightly associated 
for cage formation during chromosome selection or PBE. Comparison with the ORC4-FlAsH 
produced in embryos provided us a means to test our hypothetical model as this construct 
contains only minor perturbation within the C-termini. Images from this variant were drastically 
different whereby distinct concentration patterns of ORC4 where observed under intensity 
measurements, unlike ORC4-eGFP, indicating that this variant can be segregated to unique areas 
of the embryo (Fig. 4.4B and C).  Likewise, the majority (>90%) of PBs imaged had phasor 
points corresponding to bound FlAsH, they presented with unique structures (Fig. 4.7C and 
4.8C). This comparison provides more support that ORC4-eGFP is not used by embryos for PBE 
and that the phasor points observed inside PB likely originate from stochastic diffusion of the 
construct.  It is our conclusion then that the addition of eGFP causes disruption of higher order 
self-association of ORC4 that is required for cage formation.  This model also states that the lack 
of significant modifications of the ORC4-FlAsH variant would cause minimal, if any, alterations 
in structure or energy of interaction; thus allowing for it to be integrated with endogenous protein 
during activity.   
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The most characterized function of ORC4 is DNA licensing which occurs inside the PN 
during cell division (17). We interrogated the lifetime of our constructs at different points during 
embryo maturation to see if our constructs could be found within the PN (Fig. 4.3 and 4.8). 
Phasor points corresponding to ORC4-eGFP and ORC4-FlAsH were spatially resolved within 
the PN, however, the points from both variants were not identical to the points found inside the 
embryo.  The lifetime, which is being represented by the phasor points, is a measurement of the 
time it takes for the excited electron to return to the ground state in the presence of all the 
deactivation rates acting on the fluorescent molecule at that time.  Phasor point differences 
observed for both eGFP and FlAsH indicates that the environment around the fluorescent 
molecule, which can be inferred to ORC4 as well, is not identical when located between the PN 
and embryo.  Also, the phasor points that spatially and temporally resolve for the PN was also 
found to highlight regions around the PM (Fig. 4.8).  FLIM-phasor analysis establishes that not 
only can both constructs enter the PN but the forces acting upon ORC4 within the embryo is not 
identical to when bound to the PM or within the PN. The requirements for binding to the PM or 
complex formation during licensing within the PN are likely different.     
This work demonstrates that the addition of a large polypeptide to the C-termini 
negatively impacts higher order self-association of ORC4, specifically affecting structured 
organization required for cage formation, and ORC4 activity in PBE. Our ultimate goal is to use 
single particle tracking and nano-imaging to provide a detailed molecular mechanism of ORC4 
dynamics beginning with activation of the oocyte up to cell division. Fluorescent tracking of 
ORC4 will, therefore, require the use of constructs that do not significantly alter the mass of the 
protein to ensure the dual functions assigned to ORC4, PBE and DNA licensing, are not altered 
during embryo maturation.  Herein we describe a possible ORC4 construct, namely ORC4 with a 
FlAsH sequence at site Cys-Cys-Pro-Gly-Cys-Cys, which allows for site-specific labeling and 
minimal background signal from nonspecific binding within live embryos.  This work also 
represents the first step towards establishing a transgenic mouse model expressing endogenous 
levels of a trackable variant of ORC4.   
4.5 Contributions 
Research design: Hieu Nguyen, Nicholas G. James, and W. Steven Ward 
Conducted experiments: Hieu Nguyen, Nicholas G. James, and Brandon Nguyen 
Contributed to writing: Hieu Nguyen and Nicholas G. James 
63 
 
  
Figure 4.1. Graphical representation of Phasor plot. The phasor point location is a vector with a length 
equal to the modulation (M) at an angle equal to the phase delay (ϕ). For a fluorophore with a single 
exponential, this vector describes a semicircle of 0.5 with a center at (0.5, 0); this semicircle is referred to 
the universal circle.   
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Figure 4.2. Spatial and temporal analysis reveals minimal self-association of ORC4-eGFP in 
embryos. (A-C) Representative intensity image of non-injected embryos (A; maximum intensity 10 
counts at a single pixel), mRNA eGFP injected embryos (B; maximum intensity 100 counts at a single 
pixel), and ORC4-eGFP mRNA injected embryos (C; maximum intensity 50 counts at a single pixel). 
Scale bar is 15 microns. (D) Phasor points of reprehensive embryos with no mRNA injected (red), eGFP 
mRNA injected (green), and ORC4-eGFP mRNA injected (blue).  
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Figure 4.3. FLIM-phasor method demonstrates minimal amount of ORC4-eGFP entering the PB. 
(A) Phasor plot of an embryo injected with ORC4-eGFP mRNA.  The blue circle correlates with Phasor 
points for ORC4-eGFP while the red points are more indicative of autofluorescence excited state 
properties. (B) Spatial organization of the phasor points from (A). The green points are found located 
within the cytosol and the red is located within the areas near the PB.  Scale bar is 15 microns.                  
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Figure 4.4. FLIM-phasor method during G1 phase indicates that ORC4-eGFP can enter the PN. 
(A) Intensity image of embryos injected with ORC4-eGFP mRNA during blank phase.  Scale bar is 10 
microns. (B) Corresponding phasor points from (A). Points circled in blue represent phasor points in 
similar proximity as those obtained for ORC4-eGFP at previous stages of division while the other circle 
indicates phasor points that appear in embryos that highlight the PN. (C) Spatial organization of the 
phasor points from (B) organized within the image from (A). The blue points are found located within the 
PN and are shown to be shifted away from the phasor point population of ORC4-eGFP within embryos.                  
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Figure 4.5. Visual observation of ORC4-eGFP self-association in embryos with RICS analysis. The 
intensity image of embryos injected with ORC4-eGFP mRNA (A) reveals a population wherein ORC4-
eGFP is self-associated (B) when the pixel size is set to 50 nms. Scale bar for (A) 10 microns and from 
(B) is 3 microns.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B A 
Anaphase II ORC4-eGFP self-association 
68 
 
 
 
 
Figure 4.6: Formation of FlAsH-tetracysteine adduct. The stability of FlAsH-EDT2 has been shown by 
the binding of cysteine residues to arsenic compounds via strong sulfur-arsenic bond. FlAsH-EDT2 is a 
pale yellow color and it becomes fluorescent via the binding of tetracysteine motif. 
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Figure 4.7. ORC4-FlAsH confocal images demonstrate unique structural organizations during cell 
division. Representative intensity images of embryos with laser excitation at 780 nm. A) No mRNA 
injected and no FlAsH added. Autofluorescence had a maximum intensity (red pixels) of 6 counts. B) No 
mRNA injected and FlAsH added.  Nonspecific bound FlAsH was found to have a maximum intensity 
(red pixels) of 15 counts. C) ORC4-FlAsH mRNA injected and FlAsH added.  FlAsH was found to have 
a maximum intensity (red pixels) of 100 counts. Scale bars represent 15 microns. D) Phasor plot showing 
representative phasor points from embryo Autofluorescence (red), embryos incubated with FlAsH without 
mRNA injected (green), and embryos incubated with FlAsH and injected with ORC4-FlAsH mRNA. 
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Figure 4.8. ORC4-FlAsH phasor points demonstrate entry within the PN and different properties 
when bound to the plasma membrane. Spatial distribution of FlAsH lifetime during GI phase.  A) 
Intensity image during blank phase after mRNA injection and Treatment with FlAsH.  B) Phasor points of 
each pixel obtained from FLIM of image A.  Circle were created to center around areas with a large 
number of phasor points as calculated from SimFCS. Green circle highlights PN and the plasma 
membrane; Red and Dark Green circles highlight pixels within the cytosol.  C) Spatial distribution of 
phasor points overlayed onto A.  Scale bars represent 15 microns. 
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Embryo (920 nm)* G S 
Autofluorescence 0.31 (± 0.01) 0.21 (± 0.01) 
eGFP  0.31 (± 0.01) 0.45 (± 0.01) 
ORC4-eGFP 0.33 (± 0.02) 0.33 (± 0.01) 
Embryo (780 nm)* G S 
Autofluorescence 0.38 (± 0.01) 0.21 (± 0.01) 
FlAsH  (no mRNA) 0.23 (± 0.03) 0.39 (± 0.01) 
ORC4-FlAsH 0.36 (± 0.02) 0.33 (± 0.02) 
 
Table 4.1.  Statistical analysis of Phasor point locations for ORC4-eGFP and ORC4-FlAsH.  * N = 
10; G and S values are an average from all embryos imaged and represent the area within the phasor plot 
that contains the highest number of pixels for each condition.  Calculations were performed using the 
FLIM program on SimFCS4.0 (Gratton, UCI).    
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CHAPTER 5: CONCLUSION  
5.1 ORC4 involves in polar body extrusion 
The observations described in this dissertation raised the intriguing question that 
cytoplasmic ORC4 plays a role in the separation of the polar bodies from the oocyte. Contrary to 
common knowledge of ORC4 and its role in DNA licensing, this unusual behavior of ORC4 lead 
to my focus for my dissertation, which was to explore the new function of this protein and its 
role in polar body extrusion. In this section, we would like to summarize evidence we observed 
through our experiments that suggest ORC4 is involved in polar body extrusion, and to speculate 
on what it means for the cell biology of meiosis. In our initial work using ICC to observe the 
ORC4 signals, due to the possibility of off-target effect of the antibodies we were unsure that the 
ORC4 signal is true. To address this, we expressed the ORC4-HIS protein using mouse ORC4 
with histidine tag constructs. This result demonstrated that our prior ICC experiments identified 
ORC4. As mentioned, the ORC4 surrounds the first and second polar bodies. When we induced a 
pseudo-polar body using inactivated sperm, an ORC4 cage then formed around the sperm 
chromatin that was expelled (Fig. 3.6, chapter 3). During normal fertilization sperm chromatin 
does not extrude a polar body because its chromatin must fuse with maternal chromatin for 
normal development.  This is the reason why we did not observe any ORC4 cage-like structure 
form around the paternal chromosome.  It is only when we induce the paternal chromosomes to 
develop a pseudo-polar body that we observed the formation of this structure. Following with 
this result, it is clear that the ORC4 cage is associated with the extruded chromatin or PB, 
however further investigation was needed to understand it role in polar body extrusion.  The 
most direct evidence that the ORC4 cage is required for PBE is that ORC4 peptides that were 
injected into the oocyte prevented the formation of the ORC4 cage (Fig. 3.8, chapter 3). Future 
work will be focused on understanding the mechanisms of how the ORC4 cage coordinates PBE 
and DNA replication. 
5.2 Possible mechanisms that ORC4 may act 
We have shown that ORC4 has a new function in polar body extrusion; however, the 
findings from this research are relatively new, and the exact mechanism of ORC4 plays during 
polar body extrusion is not yet known.  With continued efforts, we hope to understand its role. 
There are some theories we have regarding its mechanism that we believe should be tested to 
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determine the exact pathway. The mammalian oocyte undergoes two rounds of asymmetric 
division to generate a large oocyte in addition to two smaller polar bodies. The asymmetric 
division results from oocyte polarization including cortical polarity, migration, and spindle 
position. This process is essential for fertilization and maintenance of maternal genetic 
information in the early stages of embryo development (91). The asymmetric spindle positioning 
plays a critical role in polar body formation. In each meiotic division, the meiotic spindle has to 
be positioned on one particular side of the cortex. After GVBD, the meiotic spindle is located 
near the cell center and migrates towards one side of the cortex shortly after. The meiotic spindle 
formation is then completed at metaphase I. The spindle migrates to near cortex and arranges 
itself perpendicular to the cortex prior to anaphase and cytokinesis. The migration of the spindle 
to the cortex is necessary for asymmetric division. It is followed by the transition of anaphase I 
to telophase I. In the mature oocyte, the spindle is arrested in metaphase II. Further process will 
not proceed prior sperm entry (56) (92). During our observation of ORC4 in two meiotic 
divisions, the ORC4 cage seems to appear at the same time during which spindle transition 
occurs. The following question is raised: does the ORC4 play a role in spindle positioning? The 
BFA, a fungal toxin which is used to inhibit Golgi-based membrane vesicle fusion, has been 
shown to disrupt spindle position in the mature oocyte. When mature oocyte was treated with 
BFA, the spindle failed to arrest perpendicular position; additionally, the chromosome separated 
to develop two half-size oocytes without the formation of PB (20). In our work, when we 
incubated oocyte in the presence of BFA, we found that BFA inhibits the ORC4 cage-like 
structure from forming (Fig. 3.4, chapter 3) (79). This hinted toward the theory that the ORC4 
might play a role in spindle position. However, to understand whether the ORC4 involves in 
spindle position, more study is required.  
The asymmetric divisions rely on the spindle positioning. This process is also induced by 
the establishment of cortical polarity which is characterized by an actin domain under the control 
of a myosin ring. At anaphase, the actin domain protrudes, combining with constriction of the 
myosin ring that leads to the formation of the two polar bodies (24). The mechanism and role of 
this cortical polarity model are not completely understood. A recent report has shown that the 
establishment of cortical polarity depends on chromosome signals. Deng and colleagues have 
shown that the injected sperm head or DNA-coated beads at the cortex of MII oocytes helped to 
induce a cortical actin cap that is surrounded by a myosin ring (27). These findings suggest that 
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the cortical cap formation is regulated by chromatin induction based on a distance between 
chromatin and the cortex. This model is similar to various factors, such as the Ran guanine 
nucleotide exchange factors (GEF) and Ran GTPase activating protein, that mediate the 
chromosome signal to the cortex to induce spindle formation (93), (94). A mutant Ran in MII 
oocyte disrupts cortical polarization (95). In addition to spindle positioning and cortical 
polarization, the critical involvement of actin in this system is present in several varieties of 
species ranging from mouse to human (96), (97). During spindle migration, the actin filaments 
remained associated with spindle and was able to push the spindle toward the cortex (37). These 
literature may provide us with a possible explanation as to why ORC4 surrounds only one set of 
chromosome that will be extruded to form PB. Our unpublished data showed that ORC4 
disappeared to be associated with DNA at anaphase I and anaphase II when it was extracted with 
100 mM NaCl (Fig. 5.1). This demonstrated that ORC4 does not bind directly to DNA at these 
stages prior DNA synthesis; rather, ORC4 may bind to actin filaments or the meiotic spindle. 
When the meiotic spindle arrests and migrates to the cortex, actin polarization is induced. We 
propose that the ORC4 which plays a new function in PBE may follow this actin-based 
mechanism; however, this would not explain the phenomena of the ORC4 cage formation 
surrounding extruded chromatin and PB. Dynamic actin networks have a known function in the 
processes of cortical flows (98), tissue morphogenesis (99), cell migration (100), and 
cytoplasmic organization (101). These networks are driven by the vesicles that recruit myosin to 
reorganize actin filaments (65). Schuh and colleagues showed that vesicles, which are positive 
for the small GTPase Rab11a, function as cytoskeletal modulators. Asymmetric spindle 
positioning, the morphology and the polarization of the oocyte were affected by deletion of 
Rab11a-positive vesicles (65). The Rab11a-positive vesicles were found to interact closely with 
the exocyst, an 8-protein complex modulating budding in yeast and some types of polarized 
exocytosis in mammalian cells (102). Moreover, PARD6B, a homolog of par-6 genes and a 
member of aPCK/par polarity complex along with Par3, aPKC, and CDC42, has been shown to 
play an important role in cell polarity in many cell types (35). PARD6B is first localized on the 
spindle microtubules and accumulates at the nearest pole where the cortex is located. It was also 
found to associate with the spindle during spindle migration and to re-localize on the 
chromosomes (103). Fogelgren’s lab reported that the Par complex interacted with the exocyst 
complex to guide exocyst-mediated trafficking in some cell types (104). These interesting 
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findings in the literature might help us to understand and continue our future study the 
mechanism of ORC4 (Fig. 5.2). 
5. 3 Future plans 
 Based on our results, we can conclude that the licensing protein ORC4 is required for 
polar body extrusion; however, future research should be conducted to help clarify the exact role 
of ORC4 on PBE.  
  Firstly, our preliminary data showed that using immunocytochemistry and peptide 
disruption strongly support the idea that ORC4 is involved in PBE. We also visualized ORC4-
GFP and ORC4 labeled with FlAsH studied on live cells, but the excessive brightness of the 
ORC4-GFP signals proved to be an obstacle in tracking ORC4 cage formation. We are currently 
in the process of creating a fusion Hisidine protein with ORC4, IRES and GFP protein in the 
same plasmid (Fig. 5.3) in addition to a transgenic line by using an eGFP (ORC4-His-IRES-
GFP) at the C terminus of ORC4. This should not interfere with its role in DNA replication or in 
ORC4 cage formation. We use the fusion GFP protein that co-expression with ORC4-His to 
determine whether the ORC4-His-IRES-GFP will be transfected into mouse based on GFP 
signals, but we plan to use His tags to target ORC4 due to problems previously inherent in the 
live ORC4-GFP cells. To better understand the role of ORC4, (1) we will create the ORC4-His-
IRES-GFP construct under control of the CAG promoter (Fig. 5.3). This plasmid will then be 
transfected into HEK cells to determine whether over-expression of ORC4 causes harm to cells 
that will be used to grow in the future. If the cells survive, we will use this construct to express 
ORC4-His-IRES-GFP in all transgenic mouse cells. This method will be a useful tool for future 
studies related to the function of the DNA licensing ORC4. If the HEK cells which will be 
transfected do not survive, we will conclude that the over-expression of ORC4-His-IRES-GFP is 
lethal. In this case, we will generate a construct ORC4-His-IRES-GFP under control of ZP3 
promoter, a recognized promoter for oocyte specific expression. (2) We will create ORC4-GFP 
transgenic knock-in mice (Fig. 5.3) to insert this eGFP gene into the last exon 14 of the mouse 
ORC4 which includes 14 exons. By doing this, we will design a CRISPR guide RNA that targets 
the stop codon of ORC4 that is found after the first 186 bp of exon 14. A donor template will be 
synthesized containing a GFP gene flanked by homology arms to facilitate homology directed 
repair and insertion before the ORC4 stop codon. This will result in GFP fusion to the C-terminal 
end of endogenous ORC4 in which we expect endogenous ORC4-GFP to be expressed at its 
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normal levels because it is the endogenous gene. Thus it will not over-express to kill cells as 
ORC4 has known function on DNA replication. This method will be unlikely to harm the oocyte 
and will enable examination of ORC4 biology on mouse model. 
 Secondly, an additional direction to take in the future is to determine the mechanism of 
ORC4 cage formation on mouse model. Yi et al demonstrated that the mechanism of polar body 
extrusion on mouse is involved in actin located at the site of cytokinesis, but we propose that the 
mechanism of the ORC4 cage formation might follow another mechanism related to exocyst. As 
mentioned above, The Rab11a-positive vesicles interact closely with the exocyst and PARD6B is 
associated with exocyst-mediated trafficking in some cell types (104), while the mutation of sec, 
made of exocyst, and has been showed to prevent budding on yeast (102). When we tested 
PARD6B localization on mouse oocytes via ICC, we found that PARD6B has the same 
localization where ORC4 localization is on the oocyte during anaphase II and G1 stages (Fig. 
5.4). This result led us to propose that the mechanism of ORC4 might follows the mechanism of 
exocyst-mediated trafficking. To prove this, we will carry out some experiments. (1) We will 
perform ICC of PARD6B and exocyst proteins at meiosis II stage on mouse oocyte. (2) We will 
also test whether the siRNA-PARD6B and PARD6B peptides inhibit ORC4 cage formation and 
PBE. (3) Finally, we will determine the role of the exocyst in PBE by knocking out Pard6b and 
sec10; one of the proteins is necessary for the formation of the exocyst (104).  
 Finally, our published data found that the ORC4 surrounds the chromatin that will be 
extruded in both polar bodies during meiotic I and II on mouse oocyte. This suggests that ORC4 
might involve in asymmetric cell divisions on other cell types. The most similar cellular process 
to PBE that we found is the extrusion of the erythrocyte cell’s chromatin during the development 
of the erythroblast cell. Our preliminary data showed that ORC4 was in the cytoplasm of 
erythroblast and surrounds the ejected nucleus (Fig. 5.5). This led us to hypothesize that the 
ORC4 cage mechanism is used in other cell types for chromatin expulsion. To prove this, we will 
carry out two experiments. (1) We will test whether the ORC4 cage forms during chromatin 
expulsion by erythroblast, and (2) we will determine the role of ORC4 in erythroblast 
enucleation using transgenic mice study. 
 The experiments listed here are all future directions in which we plan to take our 
experiments. I hope to continue this work during my post-doctoral research. 
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Theoretical design: Hieu Nguyen, Ben Fogelgren, Stefan Moisyadi, Vernadeth Alarcon, and W. 
Steven Ward 
Contributed to writing: Hieu Nguyen  
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Figure 5.1: ORC4 does not bind directly on DNA at anaphase II. MII oocytes were extracted with 100 
mM NaCL to remove soluble ORC4. DAPI (Blue) and ORC4 (Green). 
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Figure 5.2: A model for ORC4 mechanism in polar body extrusion. (A) A model for Actin and ORC4 
interaction in the egg. (B) We suggests that ORC4 may interact with actin via Cdc42 and exocyst 
complex. Actin (red); ORC4 (green); and Exocyst complex (brown). 
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Figure 5.3. Generation of transgenic mouse constructs: In experiment 1, we will generate transgenic 
mice that overexpress ORC4-His-GFP under control of either the CAG or ZP3 promoters. The full length 
mRNA-orc4-his fused with eGFP will be transfected into mouse zygotes. In the experiment 2, we will 
generate transgenic mice that express the endogenous Orc4 fused with eGFP. This construct will knock-in 
into the last exon of the exon 14th of Orc4 gene. 
 
 
 
 
 
Experiment 1: Generation of Transgenic Mice Expressing ORC4-His-GFP 
  Experiment 2: Generation of Transgenic Mice Expressing Endogenous ORC4-GFP 
CAG ORC4-His GFP pA IRES ZP3 ORC4-His GFP pA IRES 
1) 2) 
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Figure 5.4. PARD6B localization on PBE. An MII oocyte (A-C) and a parthenogenetically activated 
oocytes (D-F) were stained with PARD6B (green) and ORC4 (red). Both of proteins were found at the 
site of the cortex where the first and the second polar bodies formed (double arrows). DAPI (Blue). Bar = 
10 m (unpublished data). 
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Figure 5.5. ORC4 cage formation on erythroblast chromatin ejection cells. (A-C) Normoblast stage is 
a stage just before chromatin ejection. (D-F) A normoblast ejecting the chromatin. (G-I) Ejected 
chromatin capsule. (J) MEL cell. (K-L) Enucleated MEL cell with 15M Vacuolin-1. Cells were stained 
with ORC4 (green). DAPI (blue). Bar=2 m (unpublished data). 
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